Bivalirudin
| Title | Journal |
|---|---|
| Direct thrombin inhibitor-bivalirudin functionalized plasma polymerized allylamine coating for improved biocompatibility of vascular devices. | Biomaterials 20121101 |
| Pharmacokinetic evaluation of argatroban for the treatment of acute coronary syndrome. | Expert opinion on drug metabolism & toxicology 20121101 |
| Impact of in-hospital major bleeding on outcomes in acute coronary syndromes. | Current opinion in cardiology 20121101 |
| [New anticoagulants - direct thrombin inhibitors]. | Therapeutische Umschau. Revue therapeutique 20121101 |
| Bivalirudin has its own shelf in the cath lab, eventually. | International journal of cardiology 20121018 |
| Glycoprotein IIb-IIIa inhibitors. | Cardiovascular therapeutics 20121001 |
| Comparison of bolus only with bolus plus infusion of bivalirudin in patients undergoing elective percutaneous coronary intervention: a retrospective observational study. | Journal of pharmacy practice 20121001 |
| Acute ST-elevation myocardial infarction. | Current opinion in critical care 20121001 |
| Measuring direct thrombin inhibitors with routine and dedicated coagulation assays: which assay is helpful? | American journal of clinical pathology 20121001 |
| Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials. | Circulation. Cardiovascular interventions 20121001 |
| Direct thrombin inhibitors for management of heparin-induced thrombocytopenia in patients receiving renal replacement therapy: comparison of clinical outcomes. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120915 |
| Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair. | Circulation research 20120914 |
| Translational success stories: development of direct thrombin inhibitors. | Circulation research 20120914 |
| Outcomes of patients with prior coronary artery bypass grafting and acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. | JACC. Cardiovascular interventions 20120901 |
| Association between periprocedural bleeding and long-term outcomes following percutaneous coronary intervention in older patients. | JACC. Cardiovascular interventions 20120901 |
| Safety and efficacy of bivalirudin with glycoprotein IIb/IIIa for high-risk percutaneous coronary intervention. | Indian heart journal 20120901 |
| Bivalirudin: the relevance in today's interventional practice. | Indian heart journal 20120901 |
| Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin study). | The American journal of cardiology 20120815 |
| Meta-analysis comparing bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary intervention. | The American journal of cardiology 20120815 |
| Controlled reperfusion with intravenous bivalirudin and intracoronary abciximab combination therapy in the porcine myocardial infarction model. | Thrombosis research 20120801 |
| Bivalirudin is inferior to heparin in preservation of intraoperative autologous blood. | Thrombosis research 20120801 |
| Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study. | EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20120801 |
| Platelet reactivity and percutaneous coronary intervention: another clue in the quest for the Holy Grail of tailored antithrombotic therapy? | Journal of the American College of Cardiology 20120731 |
| Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudy. | Journal of the American College of Cardiology 20120731 |
| GP IIb/IIIa inhibitors for STEMI: still the gold standard or an old survivor? | Current vascular pharmacology 20120701 |
| In the bivalirudin era, are we still looking for a potent antiplatelet agent? | Current vascular pharmacology 20120701 |
| What is the optimal antithrombotic strategy in primary percutaneous coronary intervention? | Current opinion in cardiology 20120701 |
| Understanding the cost-effectiveness of bivalirudin. | Heart (British Cardiac Society) 20120701 |
| Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score. | Journal of the American College of Cardiology 20120612 |
| New targets for anticoagulation and future perspectives. | Current drug discovery technologies 20120601 |
| New parenteral anticoagulants: focus on factor Xa and thrombin inhibitors. | Current drug discovery technologies 20120601 |
| Discovery of anticoagulant drugs: a historical perspective. | Current drug discovery technologies 20120601 |
| Effect of bivalirudin compared with unfractionated heparin plus abciximab on infarct size and myocardial recovery after primary percutaneous coronary intervention: the horizons-AMI CMRI substudy. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20120601 |
| Comparative effectiveness analysis of anticoagulant strategies in a large observational database of percutaneous coronary interventions. | Journal of interventional cardiology 20120601 |
| The effect of differing pharmacologic strategies on infarct size in primary PCI--more confirmatory data for bivalirudin. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20120601 |
| Alternative anticoagulation during cardiovascular procedures in pediatric patients with heparin-induced thrombocytopenia. | The journal of extra-corporeal technology 20120601 |
| Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI Registry. | Journal of the American College of Cardiology 20120522 |
| Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial. | Journal of the American College of Cardiology 20120515 |
| Cardiac surgery and heparin induced thrombocytopaenia (HIT): a case report and short review. | Heart, lung & circulation 20120501 |
| Advances in laboratory testing for thrombophilia. | American journal of hematology 20120501 |
| Feasibility and safety of transradial approach and bivalirudin treatment in elderly patients undergoing early invasive strategy for ACS: 'The OLDER Research Project' preliminary study. | Journal of cardiovascular medicine (Hagerstown, Md.) 20120501 |
| Direct thrombin inhibitors in cardiovascular disease. | Nature reviews. Cardiology 20120501 |
| Clinical safety of bivalirudin in patients undergoing carotid stenting. | The Journal of invasive cardiology 20120501 |
| Comparison of percutaneous coronary intervention safety before and during the establishment of a transradial program at a teaching hospital. | The American journal of cardiology 20120415 |
| Impact of anticoagulation on ionic and nonionic contrast media effect on thrombogenesis and fibrinolysis: The PEPCIT study. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20120401 |
| Bivalirudin used as alternative anticoagulant in carotid artery stenting: a single center observational study. | Journal of interventional cardiology 20120401 |
| Evaluation of dose requirements for prolonged bivalirudin administration in patients with renal insufficiency and suspected heparin-induced thrombocytopenia. | Journal of thrombosis and thrombolysis 20120401 |
| Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of acute ST-segment elevation myocardial infarction. | Heart (British Cardiac Society) 20120401 |
| Prognostic significance of elevated baseline troponin in patients with acute coronary syndromes and chronic kidney disease treated with different antithrombotic regimens: a substudy from the ACUITY trial. | Circulation. Cardiovascular interventions 20120401 |
| Cost effectiveness of anticoagulation in acute coronary syndromes. | PharmacoEconomics 20120401 |
| Bivalirudin for primary percutaneous coronary intervention in acute myocardial infarction: the HORIZONS-AMI trial. | Expert review of cardiovascular therapy 20120401 |
| Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention. | Circulation 20120320 |
| Bivalirudin in acute myocardial infarction: NICE guidance. | Heart (British Cardiac Society) 20120301 |
| The ECG as decision support in STEMI. | Danish medical journal 20120301 |
| The prognostic meaning of the full spectrum of aVR ST-segment changes in acute myocardial infarction. | European heart journal 20120201 |
| Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. | Chest 20120201 |
| Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. | Chest 20120201 |
| Glycoprotein IIb/IIIa inhibitors and bivalirudin in patients undergoing percutaneous coronary intervention. | Minerva cardioangiologica 20120201 |
| Acute stent thrombosis: technical complication or inadequate antithrombotic therapy? An optical coherence tomography study. | JACC. Cardiovascular interventions 20120201 |
| Heparin induced thrombocytopenia: case presentation and review. | Journal of clinical medicine research 20120201 |
| Prehospital treatment of patients with acute myocardial infarction with bivalirudin. | The American journal of emergency medicine 20120101 |
| Primary angioplasty in acute myocardial infarction with right bundle branch block: should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy? | European heart journal 20120101 |
| Association between bleeding severity and long-term mortality in patients experiencing vascular complications after percutaneous coronary intervention. | The American journal of cardiology 20120101 |
| Safety of bivalirudin in patients with coronary artery disease. | Expert opinion on drug safety 20120101 |
| Incidence of bleeding in renally impaired patients receiving incorrectly dosed eptifibatide or bivalirudin while undergoing percutaneous coronary intervention. | The Annals of pharmacotherapy 20120101 |
| Recent advances in epidural analgesia. | Anesthesiology research and practice 20120101 |
| Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies. | The Annals of pharmacotherapy 20120101 |
| Bivalirudin therapy is associated with improved clinical and economic outcomes in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention: results from an observational database. | Circulation. Cardiovascular quality and outcomes 20120101 |
| Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis. | BMJ (Clinical research ed.) 20120101 |
| Challenges encountered with argatroban anticoagulation during cardiopulmonary bypass. | Journal of anaesthesiology, clinical pharmacology 20120101 |
| Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapy. | Cardiology research and practice 20120101 |
| Probing high affinity sequences of DNA aptamer against VEGF165. | PloS one 20120101 |
| Comparison of bivalirudin dosing strategies using total, adjusted, and ideal body weights in obese patients with heparin-induced thrombocytopenia. | Pharmacotherapy 20120101 |
| Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options. | Vascular health and risk management 20120101 |
| Translatability scoring in drug development: eight case studies. | Journal of translational medicine 20120101 |
| Outcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplasty. | Vascular health and risk management 20120101 |
| Stroke Prevention in Atrial Fibrillation: Where are We Now? | Clinical Medicine Insights. Cardiology 20120101 |
| Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response. | Clinical pharmacology : advances and applications 20120101 |
| The avantgarde carbostent in patients scheduled for undelayable noncardiac surgery. | Thrombosis 20120101 |
| Thrombus aspiration during primary percutaneous coronary intervention is associated with reduced myocardial edema, hemorrhage, microvascular obstruction and left ventricular remodeling. | Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 20120101 |
| Rational design and characterization of D-Phe-Pro-D-Arg-derived direct thrombin inhibitors. | PloS one 20120101 |
| Current status of new anticoagulants in the management of venous thromboembolism. | Advances in hematology 20120101 |
| Hitting back HIT. | Annals of cardiac anaesthesia 20120101 |
| Distinct effects of unfractionated heparin versus bivalirudin on circulating angiogenic peptides. | PloS one 20120101 |
| Pre-emptive use of bivalirudin for emergent off-pump coronary artery bypass surgery in a suspected case of heparin-induced thrombocytopenia. | Indian journal of anaesthesia 20120101 |
| Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center. | Cardiovascular revascularization medicine : including molecular interventions 20120101 |
| Anticoagulant and antiplatelet therapy in patients with atrial fibrillation and coronary artery disease. | Thrombosis 20120101 |
| Stent thrombosis: incidence, predictors and new technologies. | Thrombosis 20120101 |
| Dabigatran for stroke prevention in nonvalvular atrial fibrillation: answers to challenging 'real-world' questions. | Thrombosis 20120101 |
| Emerging anticoagulants. | Current medicinal chemistry 20120101 |
| Bivalirudin in combination with heparin to control mesenchymal cell procoagulant activity. | PloS one 20120101 |
| Simultaneous transradial coronary and renal in stent restenosis treatment in diabetic patient with NSTEMI complicated by hypertensive emergency. | Medical archives (Sarajevo, Bosnia and Herzegovina) 20120101 |
| Heparin-induced thrombocytopenia in the pediatric population: a review of current literature. | The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG 20120101 |
| Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo. | Blood 20111215 |
| Bivalirudin for patients with ST-elevation myocardial infarction. | Lancet (London, England) 20111203 |
| Old and new antithrombotic drugs in neonates and infants. | Seminars in fetal & neonatal medicine 20111201 |
| Loading solution prevents activation damage of human platelets before lyophilization. | Cryobiology 20111201 |
| Prasugrel and bivalirudin for primary angioplasty: early results on stent thrombosis and bleeding. | International journal of cardiology 20111201 |
| [Mortality of myocardial infarction]. | Annales de cardiologie et d'angeiologie 20111201 |
| Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial. | EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20111201 |
| Almanac 2011: acute coronary syndromes. The national society journals present selected research that has driven recent advances in clinical cardiology. | Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 20111201 |
| Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction. | The New England journal of medicine 20111124 |
| Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease. | Journal of the American College of Cardiology 20111122 |
| Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial). | The American journal of cardiology 20111115 |
| Comparison of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing an invasive strategy: a meta-analysis of randomized clinical trials. | International journal of cardiology 20111103 |
| Initial experience with an institutional bridging protocol for patients with recent coronary stent implantation requiring discontinuation of dual antiplatelet therapy resulting from urgent surgery. | American journal of therapeutics 20111101 |
| Novel techniques in the use of bivalirudin for cardiopulmonary bypass anticoagulation in a child with heparin-induced thrombocytopenia. | Perfusion 20111101 |
| Effect of prolonged Bivalirudin infusion on ST-segment resolution following primary percutaneous coronary intervention (from the PROBI VIRI 2 study). | The American journal of cardiology 20111101 |
| [Proteins influencing the blood coagulation]. | Therapeutische Umschau. Revue therapeutique 20111101 |
| Direct thrombin inhibitors. | British journal of clinical pharmacology 20111001 |
| Outcomes of coronary arterial perforations during percutaneous coronary intervention with bivalirudin anticoagulation. | The American journal of cardiology 20111001 |
| Bivalirudin dosing adjustments for reduced renal function with or without hemodialysis in the management of heparin-induced thrombocytopenia. | The Annals of pharmacotherapy 20111001 |
| Bleeding risk comparing targeted low-dose heparin with bivalirudin in patients undergoing percutaneous coronary intervention: results from a propensity score-matched analysis of the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry. | Circulation. Cardiovascular interventions 20111001 |
| Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. | American heart journal 20111001 |
| Acute coronary syndromes: Antithrombotics in ACS--moving beyond unfractionated heparin. | Nature reviews. Cardiology 20110927 |
| Unfractionated heparin administration in patients treated with bivalirudin during primary percutaneous coronary intervention is associated lower mortality and target lesion thrombosis: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). | Heart (British Cardiac Society) 20110901 |
| Optimal antithrombotic treatment during primary percutaneous coronary intervention? | Heart (British Cardiac Society) 20110901 |
| Recent advances in heparin-induced thrombocytopenia. | Current opinion in hematology 20110901 |
| Bivalirudin for anticoagulation during hypothermic cardiopulmonary bypass and recombinant factor VIIa for iatrogenic coagulopathy. | The Annals of pharmacotherapy 20110901 |
| The effect of bivalirudin on costs and outcomes of treatment of ST-segment elevation myocardial infarction. | American heart journal 20110901 |
| Endoluminal treatment of peripheral chronic total occlusions using the Crosser® recanalization catheter. | The Journal of invasive cardiology 20110901 |
| Correlation of bivalirudin dose with creatinine clearance during treatment of heparin-induced thrombocytopenia. | Pharmacotherapy 20110901 |
| Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention. | JACC. Cardiovascular interventions 20110901 |
| Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. | JACC. Cardiovascular interventions 20110901 |
| Interventional cardiology: Antithrombotic drug and stent choices in primary PCI. | Nature reviews. Cardiology 20110809 |
| Safety and tolerability of high-intensity anticoagulation with bivalirudin during neuroendovascular procedures. | Neurocritical care 20110801 |
| Integrilin in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. | Journal of interventional cardiology 20110801 |
| Massive thrombosis of venous aortic coronary bypass graft treated with bivalirudin and combined technique of thrombectomy and filter distal protection. | Journal of cardiovascular medicine (Hagerstown, Md.) 20110801 |
| How serious a problem is bleeding in patients with acute coronary syndromes? | Current cardiology reports 20110801 |
| Is a metallic microcoil really a permanent embolic agent for the management of distal guidewire-induced coronary artery perforation? | Korean circulation journal 20110801 |
| Heparin-induced thrombocytopenia. | Clinical advances in hematology & oncology : H&O 20110801 |
| Statin effect on thrombin inhibitor effectiveness during percutaneous coronary intervention: a post-hoc analysis from the ISAR-REACT 3 trial. | Clinical research in cardiology : official journal of the German Cardiac Society 20110701 |
| An assay to monitor bivalirudin levels on cardiopulmonary bypass. | The Annals of thoracic surgery 20110701 |
| Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: analysis from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial. | JACC. Cardiovascular interventions 20110701 |
| Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. | Lancet (London, England) 20110625 |
| Effect of clopidogrel pretreatment on ischemic complications of percutaneous coronary intervention among bivalirudin-treated patients (from the EVENT registry). | The American journal of cardiology 20110615 |
| Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. | Journal of the American College of Cardiology 20110614 |
| Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysis. | Journal of the American College of Cardiology 20110607 |
| Clinical applications of bivalirudin in the cardiac catheterization laboratory. | Journal of cardiovascular pharmacology and therapeutics 20110601 |
| Comparison of MAX-ACT and K-ACT values when using bivalirudin anticoagulation during minimally invasive hybrid off-pump coronary artery bypass graft surgery. | Journal of cardiothoracic and vascular anesthesia 20110601 |
| Use of prolonged bivalirudin infusions following percutaneous coronary intervention. | Cardiovascular drugs and therapy 20110601 |
| Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) substudy. | Circulation. Cardiovascular interventions 20110601 |
| A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: the tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20110601 |
| Looking back into the future: desirudin in acute coronary syndromes and coronary stenting. | EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20110601 |
| Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. | JACC. Cardiovascular interventions 20110601 |
| Bivalirudin in contemporary percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes: what is the current role of platelet glycoprotein IIb/IIIa receptor inhibitor agents? | Critical pathways in cardiology 20110601 |
| Upstream treatment of acute coronary syndrome in the ED. | The American journal of emergency medicine 20110501 |
| Two hour bivalirudin infusion after PCI for ST elevation myocardial infarction. | Journal of thrombosis and thrombolysis 20110501 |
| [Bivalirudin as an anticoagulant during percutaneous coronary interventions in acute coronary syndromes: strengths and doubts]. | Revista espanola de cardiologia 20110501 |
| The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. | JACC. Cardiovascular interventions 20110501 |
| Future anticoagulants in interventional cardiology: anti-IXa and anti-Xa agents in percutaneous coronary intervention. | Future cardiology 20110501 |
| Threshold haemoglobin levels and the prognosis of stable coronary disease: two new cohorts and a systematic review and meta-analysis. | PLoS medicine 20110501 |
| Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. | Circulation 20110426 |
| Update in hematology: heparin-induced thrombocytopenia and bivalirudin. | Journal of cardiothoracic and vascular anesthesia 20110401 |
| Bivalirudin is a dual inhibitor of thrombin and collagen-dependent platelet activation in patients undergoing percutaneous coronary intervention. | Circulation. Cardiovascular interventions 20110401 |
| Bivalirudin: a pharmacoeconomic profile of its use in patients with acute coronary syndromes. | PharmacoEconomics 20110401 |
| Pediatric catheterization laboratory anticoagulation with bivalirudin. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20110401 |
| Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia. | Seminars in thrombosis and hemostasis 20110401 |
| Glycoprotein IIb/IIIa inhibitors: do they still have a role? | Journal of the American College of Cardiology 20110308 |
| The time dependence of antithrombin initiation in patients with non-ST-segment elevation acute coronary syndromes: subgroup analysis from the ACUITY trial. | Annals of emergency medicine 20110301 |
| Bivalirudin utilization in cardiac surgery: shifting anticoagulation from indirect to direct thrombin inhibition. | Canadian journal of anaesthesia = Journal canadien d'anesthesie 20110301 |
| High-shear- and-thrombin-inducible platelet adhesion and aggregation in patients undergoing percutaneous coronary intervention. Effects of unfractionated heparin versus bivalirudin. | Thrombosis and haemostasis 20110301 |
| Adjunctive pharmacologic therapy in percutaneous coronary intervention: part II anticoagulant therapy. | Coronary artery disease 20110301 |
| Evaluation of empiric versus nomogram-based direct thrombin inhibitor management in patients with suspected heparin-induced thrombocytopenia. | American journal of hematology 20110301 |
| Use of low-dose heparin with bivalirudin for ad-hoc transradial coronary interventions: experience from a single center. | The Journal of invasive cardiology 20110301 |
| Bivalirudin and transradial access--the end of the bleeding era for catheterization procedures? | The Journal of invasive cardiology 20110301 |
| Rationale and design of the INFUSE-AMI study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction. | American heart journal 20110301 |
| Heparin-induced thrombocytopenia and extracorporeal membrane oxygenation: a case report and review of the literature. | The journal of extra-corporeal technology 20110301 |
| Regarding changing outcomes and treatment strategies for wire-induced coronary perforations in the era of bivalirudin use. A word of caution concerning the use of bivalirudin during coronary intervention for lesions at high risk for perforation. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20110215 |
| Clopidogrel pretreatment in PCI: absolute requirement or obsolete myth? | International journal of cardiology 20110203 |
| New parenteral anticoagulants in development. | Therapeutic advances in cardiovascular disease 20110201 |
| New anticoagulants in children: a review of recent studies and a look to the future. | Thrombosis research 20110201 |
| New anticoagulant agents in acute coronary syndromes. | Heart (British Cardiac Society) 20110201 |
| Antithrombotic therapy in ST-segment elevation myocardial infarction. | Expert opinion on pharmacotherapy 20110201 |
| [Direct inhibitors of thrombin, hirudin, bivalirudin, and dabigatran etexilate]. | Journal des maladies vasculaires 20110201 |
| Cardiva Catalyst II vascular access management device in percutaneous diagnostic and interventional procedures with same-day discharge (Catalyst II trial). | Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 20110201 |
| Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. | American heart journal 20110201 |
| Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. | JACC. Cardiovascular interventions 20110201 |
| Direct thrombin and factor Xa inhibitors in children: a quest for new anticoagulants for children. | Wiener medizinische Wochenschrift (1946) 20110201 |
| Studies on the effects of heparin products on pregnancy-associated plasma protein A. | Clinica chimica acta; international journal of clinical chemistry 20110130 |
| Combined blockade of thrombin anion binding exosite-1 and PAR4 produces synergistic antiplatelet effect in human platelets. | Thrombosis and haemostasis 20110101 |
| A randomized pilot trial for aggressive therapeutic approaches in aspirin-resistant patients undergoing percutaneous coronary intervention. | The Journal of invasive cardiology 20110101 |
| Platelet resistance - much known and much more unknown. | The Journal of invasive cardiology 20110101 |
| Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of non-ST-segment elevation acute coronary syndromes. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20110101 |
| Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. | European heart journal 20110101 |
| Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance--the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy. | BMC medicine 20110101 |
| A network-based multi-target computational estimation scheme for anticoagulant activities of compounds. | PloS one 20110101 |
| Heparin-induced thrombocytopenia in the ICU: an overview. | Critical care (London, England) 20110101 |
| Lepirudin as an alternative to 'heparin allergy' during cardiopulmonary bypass. | Journal of cardiothoracic surgery 20110101 |
| Heparin-induced thrombocytopenia. | Journal of emergencies, trauma, and shock 20110101 |
| Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial. | BMJ (Clinical research ed.) 20110101 |
| Dealing with thrombocytopenia during anticoagulation with heparins for active venous thromboembolism: a play-it-safe practical approach. | Therapeutics and clinical risk management 20110101 |
| Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview. | Vascular health and risk management 20110101 |
| Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention. | Vascular health and risk management 20110101 |
| Tissue factor, blood coagulation, and beyond: an overview. | International journal of inflammation 20110101 |
| An optimized method to assess in vivo efficacy of antithrombotic drugs using optical coherence tomography and a modified Doppler flow system. | Journal of pharmacological and toxicological methods 20110101 |
| Role of factor xa inhibitors in cancer-associated thrombosis: any new data? | Advances in hematology 20110101 |
| Emerging therapies for acute coronary syndromes. | Frontiers in pharmacology 20110101 |
| Crystal structure of thrombin in complex with S-variegin: insights of a novel mechanism of inhibition and design of tunable thrombin inhibitors. | PloS one 20110101 |
| Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation. | Critical care (London, England) 20110101 |
| Pharmacokinetics, pharmacodynamics, tolerability and safety of single doses of bivalirudin in healthy chinese subjects. | Biological & pharmaceutical bulletin 20110101 |
| New derivative of staphylokinase SAK-RGD-K2-Hirul exerts thrombolytic effects in the arterial thrombosis model in rats. | Pharmacological reports : PR 20110101 |
| Modeling the effects of bivalirudin in cardiac surgical patients. | Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 20110101 |
| Signal protein-derived peptides as functional probes and regulators of intracellular signaling. | Journal of amino acids 20110101 |
| Bivalirudin use in an infant with persistent clotting on unfractionated heparin. | The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG 20110101 |
| Heparin versus bivalirudin for carotid artery stenting using proximal endovascular clamping for neuroprotection: results from a prospective randomized study. | Journal of vascular surgery 20101201 |
| [Evidence-based management of ST-segment elevation myocardial infarction (STEMI). Latest guidelines of the European Society of Cardiology (ESC) 2010]. | Herz 20101201 |
| Bivalirudin: a review of the pharmacology and clinical application. | Expert review of cardiovascular therapy 20101201 |
| Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia. | Pharmacotherapy 20101201 |
| [Comments on the 2010 guidelines on cardiopulmonary resuscitation of the European Resuscitation Council]. | Der Anaesthesist 20101201 |
| The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes. | JACC. Cardiovascular interventions 20101201 |
| Comparison of bivalirudin versus heparin on radial artery occlusion after transradial catheterization. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20101101 |
| Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy. | Journal of thrombosis and thrombolysis 20101101 |
| M-AAA-thrombin: potent anticoagulant and antiplatelet thrombin derivative with differential affinity for factor VIII and PAR1. | Thrombosis research 20101101 |
| Oral thrombostatin FM19 inhibits prostate cancer. | Thrombosis and haemostasis 20101101 |
| Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy. | Pharmacotherapy 20101101 |
| Radial artery occlusion- a limitation of transradial catheterization. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20101101 |
| Impact of transfer for primary percutaneous coronary intervention on survival and clinical outcomes (from the HORIZONS-AMI Trial). | The American journal of cardiology 20101101 |
| Validation of long-term benefits of bivalirudin versus unfractionated heparin in routine clinical practice after percutaneous coronary intervention. | The American journal of cardiology 20101101 |
| Economic impact of switching to bivalirudin for a primary percutaneous coronary intervention in a US hospital. | Hospital practice (1995) 20101101 |
| Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry--GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry--Get With the Guidelines). | JACC. Cardiovascular interventions 20101101 |
| The HIT treatment in a cardiac surgery patient. | International journal of cardiology 20101029 |
| Correlates and consequences of gastrointestinal bleeding complicating percutaneous coronary intervention. | The American journal of cardiology 20101015 |
| Cerebrospinal fluid drainage with bivalirudin and rFactor VIIa for thoracic aortic aneurysm surgery using left atrial-femoral artery bypass. | Journal of cardiothoracic and vascular anesthesia 20101001 |
| Bivalirudin in patients with coronary artery disease. | Cardiovascular & hematological agents in medicinal chemistry 20101001 |
| ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention. | European heart journal 20101001 |
| Comparison of Bivalirudin versus Bivalirudin plus glycoprotein IIb/IIIa inhibitor versus heparin plus glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes having percutaneous intervention for narrowed saphenous vein aorto-coronary grafts (the ACUITY trial investigators). | The American journal of cardiology 20101001 |
| Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20101001 |
| It is standard practice, but is it really best practice or clinical biocreep? | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20101001 |
| Rapid adoption of drug-eluting stents: clinical practices and outcomes from the early drug-eluting stent era. | American heart journal 20101001 |
| Transradial approach for coronary angiography and interventions: results of the first international transradial practice survey. | JACC. Cardiovascular interventions 20101001 |
| Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. | JACC. Cardiovascular interventions 20101001 |
| Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry. | JACC. Cardiovascular interventions 20101001 |
| Successful percutaneous coronary intervention for acute coronary syndrome in a patient with severe hemophilia a. | Korean circulation journal 20101001 |
| Letter by De Servi and Navarese regarding article, 'Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial'. | Circulation 20100921 |
| Treatment options in heparin-induced thrombocytopenia. | Current opinion in hematology 20100901 |
| Case report: a thrombus in the venous reservoir while using bivalirudin in a patient with heparin-induced thrombocytopenia undergoing heart transplantation. | Anesthesia and analgesia 20100901 |
| [Heparin-induced thrombocytopenia]. | Der Internist 20100901 |
| Warfarin-induced penile necrosis in a patient with heparin-induced thrombocytopenia. | Journal of Korean medical science 20100901 |
| Bivalirudin use during radiofrequency catheter ablation procedures in two patients with a history of heparin-induced thrombocytopenia. | Pharmacotherapy 20100901 |
| Use of bivalirudin for heparin-induced thrombocytopaenia after thrombolysis in massive pulmonary embolism: a case report. | International journal of emergency medicine 20100901 |
| Prognostic value of lead V1 ST elevation during acute inferior myocardial infarction. | Circulation 20100803 |
| Balancing the benefits and risks of antiplatelet agents in patients with non-ST-segment elevated acute coronary syndromes and undergoing percutaneous coronary intervention. | Journal of thrombosis and thrombolysis 20100801 |
| A pilot, prospective evaluation of a direct thrombin inhibitor, bivalirudin (Angiomax), in patients undergoing lower extremity bypass. | Journal of vascular surgery 20100801 |
| aVR ST elevation: an important but neglected sign in ST elevation acute myocardial infarction. | European heart journal 20100801 |
| The use of bivalirudin for cardiopulmonary bypass anticoagulation in pediatric heparin-induced thrombocytopenia patients. | Artificial organs 20100801 |
| Factors influencing local and systemic levels of plasma myeloperoxidase in ST-segment elevation acute myocardial infarction. | The American journal of cardiology 20100801 |
| Case report: a 55-year-old woman with chest pain upon arrival to the emergency department. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100801 |
| Pharmacologic therapy for non ST-segment elevation acute coronary syndromes: focus on antithrombotic therapy. | Cardiovascular drugs and therapy 20100801 |
| Impact of bivalirudin therapy in high-risk patients with acute myocardial infarction: 1-year results from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial. | JACC. Cardiovascular interventions 20100801 |
| Bivalirudin in acute myocardial infarction: 'primum non nocere': the eternal dilemma: balancing risks and benefits in high-risk patients. | JACC. Cardiovascular interventions 20100801 |
| Retroperitoneal hematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality: a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry. | JACC. Cardiovascular interventions 20100801 |
| Cost-effectiveness of targeting patients undergoing percutaneous coronary intervention for therapy with bivalirudin versus heparin monotherapy according to predicted risk of bleeding. | Circulation. Cardiovascular quality and outcomes 20100701 |
| A comment on laboratory monitoring of new anticoagulants. | American journal of hematology 20100701 |
| Management of protamine allergy with bivalirudin during coronary artery revascularization. | The Annals of thoracic surgery 20100701 |
| Outcomes research: the next generation. | Circulation. Cardiovascular quality and outcomes 20100701 |
| A risk score to predict bleeding in patients with acute coronary syndromes. | Journal of the American College of Cardiology 20100608 |
| Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. | JAMA 20100602 |
| Use of platelet glycoprotein IIb/IIIa inhibitors in diabetics undergoing PCI for non-ST-segment elevation acute coronary syndromes: impact of clinical status and procedural characteristics. | Clinical research in cardiology : official journal of the German Cardiac Society 20100601 |
| Anesthetic concerns for patients with coagulopathy. | Current opinion in anaesthesiology 20100601 |
| Bivalirudin during percutaneous coronary interventions in patients with ST segment elevation myocardial infarction. | Acute cardiac care 20100601 |
| The impact of bivalirudin on percutaneous coronary intervention-related bleeding. | EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20100601 |
| Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. | American heart journal 20100601 |
| Body mass index and bleeding complications after percutaneous coronary intervention: does bivalirudin make a difference? | American heart journal 20100601 |
| Antithrombotic strategy in non-ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry. | JACC. Cardiovascular interventions 20100601 |
| Why we do what we do? Making sense of antithrombotic therapy in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. | JACC. Cardiovascular interventions 20100601 |
| Safety and efficacy of bivalirudin for percutaneous coronary intervention with rotational atherectomy. | Journal of interventional cardiology 20100601 |
| Bivalirudin for mechanical rotational atherectomy: the quest for better outcomes. | Journal of interventional cardiology 20100601 |
| Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial). | The American journal of cardiology 20100515 |
| Bivalirudin: in patients with ST-segment elevation myocardial infarction. | Drugs 20100507 |
| Development and validation of a LC-MS/MS method for determination of bivalirudin in human plasma: Application to a clinical pharmacokinetic study. | Journal of pharmaceutical and biomedical analysis 20100501 |
| Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive factors. | European heart journal 20100501 |
| The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis. | Thrombosis and haemostasis 20100501 |
| Comparison of bivalirudin and unfractionated heparin plus protamine in patients with coronary heart disease undergoing percutaneous coronary intervention (from the Antithrombotic Regimens aNd Outcome [ARNO] trial). | The American journal of cardiology 20100415 |
| Frequency and safety of switching antithrombin therapy at a regional PCI center. | Journal of thrombosis and thrombolysis 20100401 |
| [Clinical and economical evaluation of bivalirudin during percutaneous coronary interventions]. | Annales de cardiologie et d'angeiologie 20100401 |
| Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleeding. | Journal of thrombosis and haemostasis : JTH 20100401 |
| Recombinant factor VIIa to manage major bleeding from newer parenteral anticoagulants. | The Annals of pharmacotherapy 20100401 |
| Outcomes of Patients with coronary artery perforation complicating percutaneous coronary intervention and correlations with the type of adjunctive antithrombotic therapy: pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials. Heparin only should be considered for lesions at high risk for perforation. | Journal of interventional cardiology 20100401 |
| Practical strategies for the management of anticoagulation therapy: unsolved issues in the cardiac catheterization laboratory. | Cardiovascular drugs and therapy 20100401 |
| Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention. | European heart journal 20100301 |
| Laboratory monitoring of new anticoagulants. | American journal of hematology 20100301 |
| Which antithrombotic to use during PCI? | European heart journal 20100301 |
| Bivalirudin vs. unfractionated heparin during percutaneous coronary interventions in patients with stable and unstable angina pectoris: 1-year results of the ISAR-REACT 3 trial. | European heart journal 20100301 |
| Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practice. | The Journal of invasive cardiology 20100301 |
| Anticoagulation during percutaneous coronary intervention in diabetics--is simpler always better? | The Journal of invasive cardiology 20100301 |
| Heparin-induced thrombocytopenia. | Seminars in cardiothoracic and vascular anesthesia 20100301 |
| Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudy. | Circulation 20100223 |
| Treating non-ST-segment elevation acute coronary syndromes: if you aren't sure, at least do no harm. | Circulation 20100223 |
| Carotid stenting and bivalirudin with and without vascular closure: 3-year analysis of procedural outcomes. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20100215 |
| Heparin-induced thrombocytopenia and cardiac surgery. | Current opinion in anaesthesiology 20100201 |
| Antiplatelet and anticoagulant therapies in acute coronary syndromes. | Cardiovascular drugs and therapy 20100201 |
| Safety and in-hospital outcomes of bivalirudin use in dialysis patients undergoing percutaneous coronary intervention. | The American journal of cardiology 20100201 |
| Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. | Circulation. Cardiovascular interventions 20100201 |
| Anticoagulant therapy for percutaneous coronary intervention. | Circulation. Cardiovascular interventions 20100201 |
| In-hospital safety and effectiveness of bivalirudin in percutaneous peripheral interventions: data from a real-world registry. | Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 20100201 |
| Commentary: bivalirudin is a safe and effective anticoagulant in the percutaneous treatment of complex infrainguinal disease. | Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 20100201 |
| HORIZONS-AMI. | Lancet (London, England) 20100130 |
| Bleeding after percutaneous coronary intervention with Bivalirudin or unfractionated Heparin and one-year mortality. | The American journal of cardiology 20100115 |
| Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial. | Circulation 20100105 |
| Failed pericardiocentesis for acute cardiac tamponade: two cases associated with bivalirudin administration during PCI. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20100101 |
| Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials. | European heart journal 20100101 |
| Heart transplantation using bivalirudin as anticoagulant. | Interactive cardiovascular and thoracic surgery 20100101 |
| Bivalirudin: alternative anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia. | Recent patents on cardiovascular drug discovery 20100101 |
| Effect of hirulog-like peptide on balloon catheter injury-induced neointimal formation in femoral arteries of minipigs and relationship with inflammatory mediators. | Journal of vascular research 20100101 |
| Platelet thrombin receptor antagonism and atherothrombosis. | European heart journal 20100101 |
| A poly-N-acetyl glucosamine hemostatic dressing for femoral artery access site hemostasis after percutaneous coronary intervention: a pilot study. | The Journal of invasive cardiology 20100101 |
| A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: design and statistical methods of the PERSEUS clinical program. | Trials 20100101 |
| Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: the EQUIP-ACS project protocol and design. | Trials 20100101 |
| In-stent thrombosis after 68 months of implantation inspite of continuous dual antiplatelet therapy: a case report. | Cases journal 20100101 |
| Antithrombotic therapy in patients with coronary artery disease and with type 2 diabetes mellitus. | Wiener medizinische Wochenschrift (1946) 20100101 |
| Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention. | Vascular health and risk management 20100101 |
| Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies. | Vascular health and risk management 20100101 |
| Heparin-induced thrombocytopenia: a practical review. | Reviews in cardiovascular medicine 20100101 |
| New options with dabigatran etexilate in anticoagulant therapy. | Vascular health and risk management 20100101 |
| Actual Role of Platelet Glycoprotein IIb/IIIa Receptor Inhibitors as Adjunctive Pharmacological Therapy to Primary Angioplasty in Acute Myocardial Infarction: In the Light of Recent Randomized Trials and Observational Studies with Bivalirudin. | The open cardiovascular medicine journal 20100101 |
| Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome. | Drug design, development and therapy 20100101 |
| Argatroban in the management of heparin-induced thrombocytopenia. | Vascular health and risk management 20100101 |
| GPIIb/IIIa Receptor Antagonism Using Small Molecules Provides no Additive Long-Term Protection after Percutaneous Coronary Intervention as Compared to Clopidogrel Plus Aspirin. | The open cardiovascular medicine journal 20100101 |
| Post-operative thromboprophylaxis: new oral thrombin and factor X inhibitors and their place in clinical practice. | F1000 medicine reports 20100101 |
| Antiphospholipid syndrome; its implication in cardiovascular diseases: a review. | Journal of cardiothoracic surgery 20100101 |
| Bivalirudin: a review of pharmacology and therapeutic use. | Connecticut medicine 20100101 |
| Transradial vs femoral percutaneous coronary intervention for left main disease in octogenarians. | Indian heart journal 20100101 |
| Our technique for transradial coronary angiography and interventions. | Indian heart journal 20100101 |
| Profound thrombocytopenia after primary exposure to eptifibatide. | Drug, healthcare and patient safety 20100101 |
| The Potential Value of Near Patient Platelet Function Testing in PCI: Randomised Comparison of 600 mg versus 900 mg Clopidogrel Loading Doses. | Thrombosis 20100101 |
| Emerging antiplatelet agents, differential pharmacology, and clinical utility. | Journal of blood medicine 20100101 |
| Oral antiplatelet therapy for acute and chronic management of NSTE ACS: residual ischemic risk and opportunities for improvement. | Cardiovascular drugs and therapy 20091201 |
| Avoiding intelligence failures in the cardiac catheterization laboratory: Strategies for the safe and rational use of dalteparin or enoxaparin during percutaneous coronary intervention. | The Journal of invasive cardiology 20091201 |
| Changing outcomes and treatment strategies for wire induced coronary perforations in the era of bivalirudin use. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20091101 |
| Comparison of bivalirudin monotherapy versus unfractionated heparin plus tirofiban in patients with diabetes mellitus undergoing elective percutaneous coronary intervention. | The American journal of cardiology 20091101 |
| ''They can always hurt you more'' bivalirudin and the dynamic balance between bleeding and clotting. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20091101 |
| Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials. | European heart journal 20091101 |
| Comparison of prolonged bivalirudin infusion versus intraprocedural in preventing myocardial damage after percutaneous coronary intervention in patients with angina pectoris. | The American journal of cardiology 20091015 |
| Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. | Journal of the American College of Cardiology 20091006 |
| The changing horizon of acute coronary syndrome. | Lancet (London, England) 20091003 |
| Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. | Lancet (London, England) 20091003 |
| Outcomes of patients with coronary artery perforation complicating percutaneous coronary intervention and correlations with the type of adjunctive antithrombotic therapy: pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials. | Journal of interventional cardiology 20091001 |
| Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry. | Circulation. Cardiovascular interventions 20091001 |
| Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. | Journal of the American College of Cardiology 20090929 |
| Otamixaban in acute coronary syndromes. | Lancet (London, England) 20090905 |
| Noncompetitive inhibitor of thrombin. | Chembiochem : a European journal of chemical biology 20090904 |
| Impact of bivalirudin on in-hospital bleeding and six-month outcomes in octogenarians undergoing percutaneous coronary intervention. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20090901 |
| Heparin induced thrombocytopenia and re-thrombosis associated with warfarin and fondaparinux in a child. | Pediatric blood & cancer 20090901 |
| Oldies but goodies. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20090901 |
| Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty: A meta-analyis of randomised trials. | Thrombosis and haemostasis 20090901 |
| Patient satisfaction is comparable to early discharge versus overnight observation after elective percutaneous coronary intervention. | The Journal of invasive cardiology 20090901 |
| Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in percutaneous peripheral intervention: a single-center experience. | JACC. Cardiovascular interventions 20090901 |
| [What's new on antithrombotics?]. | Annales de cardiologie et d'angeiologie 20090801 |
| A novel hirudin derivative characterized with anti-platelet aggregations and thrombin inhibition. | Journal of thrombosis and thrombolysis 20090801 |
| Regulation of PAR-1 in patients undergoing percutaneous coronary intervention: effects of unfractionated heparin and bivalirudin. | European heart journal 20090801 |
| Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex percutaneous coronary interventions: a descriptive study. | Coronary artery disease 20090801 |
| Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors. | Journal of cardiovascular medicine (Hagerstown, Md.) 20090801 |
| [New anticoagulants for secondary haemostasis--anti IIa inhibitors]. | Hamostaseologie 20090801 |
| Safety and efficacy of bivalirudin in high-risk patients admitted through the emergency department. | Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 20090801 |
| Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy. | JACC. Cardiovascular interventions 20090801 |
| Balancing potency of platelet inhibition with bleeding risk in the early treatment of acute coronary syndrome. | The western journal of emergency medicine 20090801 |
| A comparison of anticoagulation with bivalirudin and provisional GPIIb/IIIa inhibition with unfractionated heparin and mandatory GPIIb/IIIa inhibition during percutaneous coronary intervention in relation to platelet activation and the inhibition of coagulation. | EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20090801 |
| Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. | Journal of the American College of Cardiology 20090728 |
| Intracoronary bivalirudin for no reflow reversal: a second chance to treat this disorder? | Journal of thrombosis and thrombolysis 20090701 |
| Lack of early augmentation of platelet reactivity after coronary intervention in patients treated with bivalirudin. | Journal of thrombosis and thrombolysis 20090701 |
| New antithrombotic agents in acute coronary syndromes. | Current opinion in cardiology 20090701 |
| Prefilter bivalirudin for preventing hemofilter occlusion in continuous renal replacement therapy. | The Annals of pharmacotherapy 20090701 |
| Bivalirudin as an anticoagulant for simultaneous integrated coronary artery revascularization - a novel approach to an inherent concern. | The Canadian journal of cardiology 20090701 |
| Expert consensus on treatment strategies in non- ST-segment elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention--an evidence-based review of clinical trial results and treatment guidelines from an emergency medicine perspective: report on a roundtable discussion. | The American journal of emergency medicine 20090701 |
| Feasibility and safety of prehospital administration of bivalirudin in patients with ST-elevation myocardial infarction. | The American journal of cardiology 20090615 |
| Hotline sessions presented at the American College of Cardiology Congress 2009. | Clinical research in cardiology : official journal of the German Cardiac Society 20090601 |
| Direct thrombin inhibitors in patients with mechanical heart valves: ready for clinical trials? | Thrombosis and haemostasis 20090601 |
| Argatroban and bivalirudin compared to unfractionated heparin in preventing thrombus formation on mechanical heart valves. Results of an in-vitro study. | Thrombosis and haemostasis 20090601 |
| Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention. | The Journal of invasive cardiology 20090601 |
| Provisional use of glycoprotein IIb/IIIa inhibitors in the era of dual antiplatelet therapy--do 'bailouts' pay off? | The Journal of invasive cardiology 20090601 |
| Hospitals with and without percutaneous coronary intervention capability: considerations for treating acute coronary syndromes. | The American journal of emergency medicine 20090601 |
| Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management. | Chest 20090601 |
| Diabetes and acute coronary syndromes. | Best practice & research. Clinical endocrinology & metabolism 20090601 |
| Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. | Journal of the American College of Cardiology 20090526 |
| Lepirudin-induced thrombocytopenia following subcutaneous administration. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20090501 |
| Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial). | The American journal of cardiology 20090501 |
| Pharmacological and clinical profile of bivalirudin in the treatment of patients with acute coronary syndrome. | Expert opinion on drug metabolism & toxicology 20090501 |
| Choice of arterial access site and outcomes in patients with acute coronary syndromes managed with an early invasive strategy: the ACUITY trial. | EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20090501 |
| Click-chemistry-conjugated oligo-angiomax in the two-dimensional DNA lattice and its interaction with thrombin. | Biomacromolecules 20090413 |
| Management of patients with unstable angina / non-ST-elevation myocardial infarction: a critical review of the 2007 ACC /AHA guidelines. | International journal of clinical practice 20090401 |
| Successful use of bivalirudin for combined carotid endarterectomy and coronary revascularization with the use of cardiopulmonary bypass in a patient with an elevated heparin-platelet factor 4 antibody titer. | Anesthesia and analgesia 20090401 |
| Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions. | Diabetes care 20090401 |
| Cost-effectiveness analysis of anticoagulation strategies in non-ST-elevation acute coronary syndromes. | The Annals of pharmacotherapy 20090401 |
| Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. | Journal of the American College of Cardiology 20090324 |
| Abbreviated infusion of eptifibatide after successful coronary intervention The BRIEF-PCI (Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention) randomized trial. | Journal of the American College of Cardiology 20090310 |
| Resolution of a coronary embolus by intravenous application of bivalirudin. | International journal of cardiology 20090306 |
| Streamlining the design of promising clinical trials: in-vitro testing of antithrombotic regimens and multiple agonists of platelet activation. | Coronary artery disease 20090301 |
| Bivalirudin use during PCI for stent thrombosis in a patient with subacute intracranial hemorrhage. | The Journal of invasive cardiology 20090301 |
| Clinical cross-reactivity between danaparoid and heparin antibodies successfully managed with bivalirudin. | The Israel Medical Association journal : IMAJ 20090301 |
| Bioline heparin-coated ECMO with bivalirudin anticoagulation in a patient with acute heparin-induced thrombocytopenia: the immune reaction appeared to continue unabated. | Perfusion 20090301 |
| Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study. | Journal of the American College of Cardiology 20090224 |
| Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial. | Circulation 20090210 |
| Relationship of QRS duration at baseline and changes over 60 min after fibrinolysis to 30-day mortality with different locations of ST elevation myocardial infarction: results from the Hirulog and Early Reperfusion or Occlusion-2 trial. | Heart (British Cardiac Society) 20090201 |
| Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention. | European heart journal 20090201 |
| Heparin-induced thrombocytopenia: what clinicians need to know. | Thrombosis and haemostasis 20090201 |
| Bivalirudin reduces platelet and monocyte activation after elective percutaneous coronary intervention. | Thrombosis and haemostasis 20090201 |
| Pharmacotherapy of acute coronary syndrome: the ACUITY trial. | Expert opinion on pharmacotherapy 20090201 |
| HORIZONS trial: a step forward for primary percutaneous coronary intervention. | Expert review of cardiovascular therapy 20090201 |
| Impact of bivalirudin use on outcomes in nonagenarians undergoing percutaneous coronary intervention. | Journal of interventional cardiology 20090201 |
| Avoiding and managing bleeding complications in patients with non-ST-segment elevation acute coronary syndromes. | Angiology 20090101 |
| Cloning and expression of a new recombinant thrombolytic and anthithrombotic agent - a staphylokinase variant. | Acta biochimica Polonica 20090101 |
| Clinical experience with the use of bivalirudin in a large population undergoing endovascular abdominal aortic aneurysm repair. | Journal of vascular and interventional radiology : JVIR 20090101 |
| Re-evaluating risk factors for periprocedural complications during percutaneous coronary intervention in patients with unstable angina/non-ST-elevation myocardial infarction: who may benefit from more intensive antiplatelet therapy? | Current opinion in cardiology 20090101 |
| Antiplatelet intervention in acute coronary syndrome. | American journal of therapeutics 20090101 |
| Catheter-related thrombosis: biological and clinical evidence for risk with currently available anticoagulants. | Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20090101 |
| Use of clopidogrel in the reduction of myocardial damage during percutaneous coronary intervention. | Vascular health and risk management 20090101 |
| Bivalirudin anticoagulation during cardiac surgery: a single-center experience in 141 patients. | Perfusion 20090101 |
| Improving adjunctive pharmacotherapy for primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: beyond the HORIZONS-AMI trial. | Reviews in cardiovascular medicine 20090101 |
| Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty. | Cardiovascular revascularization medicine : including molecular interventions 20090101 |
| The in vitro effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets. | Acta poloniae pharmaceutica 20090101 |
| Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction. | Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 20090101 |
| Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention. | Vascular health and risk management 20090101 |
| [Bivalirudine in heparin-induced thrombocytopenia]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20090101 |
| Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration. | Trials 20090101 |
| Review of the treatment of acute coronary syndrome in elderly patients. | Clinical interventions in aging 20090101 |
| Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation. | Hematology. American Society of Hematology. Education Program 20090101 |
| Eptifibatide: The evidence for its role in the management of acute coronary syndromes. | Core evidence 20090101 |
| Bivalirudin for anticoagulation in children. | Pediatric blood & cancer 20081201 |
| Differential effects of factor IIa inhibitors on the endogenous thrombin potential. | Therapeutic drug monitoring 20081201 |
| Anticoagulant characteristics of HD1-22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase. | Journal of thrombosis and haemostasis : JTH 20081201 |
| Successful use of argatroban during the third trimester of pregnancy: case report and review of the literature. | Pharmacotherapy 20081201 |
| [Pharmacology of heparins and direct anticoagulants]. | Hamostaseologie 20081201 |
| Emergence of new oral antithrombotics: a critical appraisal of their clinical potential. | Vascular health and risk management 20081201 |
| Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. | JACC. Cardiovascular interventions 20081201 |
| Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes. | Journal of the American College of Cardiology 20081125 |
| Bivalirudin decreases NO bioavailability by vascular immobilization of myeloperoxidase. | The Journal of pharmacology and experimental therapeutics 20081101 |
| Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases. | Pharmacotherapy 20081101 |
| Successful use and dosing of bivalirudin after temporary total artificial heart implantation: a case series. | Pharmacotherapy 20081101 |
| 'Bail-out' bivalirudin use in patients with thrombotic complications unresponsive to conventional treatment during percutaneous coronary intervention. | The Journal of invasive cardiology 20081101 |
| IIb or not IIb. | Journal of the American College of Cardiology 20081007 |
| Coronary stenting with MGuard: first-in-man trial. | The Journal of invasive cardiology 20081001 |
| Percutaneous coronary intervention and the use of glycoprotein IIb/IIIa inhibitors in patients with chronic kidney disease on dialysis: a single center experience. | Hemodialysis international. International Symposium on Home Hemodialysis 20081001 |
| Comparison of bivalirudin, enoxaparin, and unfractionated heparin in preventing cardiac catheter thrombosis. Results of an in-vitro study. | Thrombosis and haemostasis 20081001 |
| The use of adjunctive anticoagulants in patients with acute coronary syndrome transitioning to percutaneous coronary intervention. | The American journal of emergency medicine 20081001 |
| [The HORIZONS-AMI trial]. | Giornale italiano di cardiologia (2006) 20081001 |
| Bivalirudin reduced major bleeding and adverse events in patients with STEMI having PCI. | ACP journal club 20080916 |
| Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. | Journal of the American College of Cardiology 20080902 |
| [Antithrombotic therapy of acute myocardial infarction]. | Der Internist 20080901 |
| Bivalirudin for patients with heparin-induced thrombocytopenia undergoing cardiovascular surgery. | The Annals of pharmacotherapy 20080901 |
| Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia. | Pharmacotherapy 20080901 |
| Simultaneous integrated coronary artery revascularization with long-term angiographic follow-up. | The Journal of thoracic and cardiovascular surgery 20080901 |
| Lepirudin in the management of patients with heparin-induced thrombocytopenia. | Biologics : targets & therapy 20080901 |
| Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. | The New England journal of medicine 20080814 |
| Bivalirudin with provisional glycoprotein IIb/IIIa inhibitors in patients undergoing primary angioplasty in the setting of cardiogenic shock. | The American journal of cardiology 20080801 |
| Optimizing antithrombotic therapy in patients with non-ST-segment elevation acute coronary syndrome. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080801 |
| Advances in antithrombotic therapy as adjunct to reperfusion therapies for ST-segment elevation myocardial infarction. | Thrombosis and haemostasis 20080801 |
| Antons syndrome in a patient with type-2 heparin-induced thrombocytopaenia (HIT). | Acta anaesthesiologica Scandinavica 20080801 |
| Treatment strategies in non-ST-elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention: an evidence-based review of clinical trial results and treatment guidelines: report on a roundtable discussion. | Journal of interventional cardiology 20080801 |
| Pharmacological prevention of peri-, and post-procedural myocardial injury in percutaneous coronary intervention. | Current cardiology reviews 20080801 |
| Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris. | The American journal of cardiology 20080715 |
| Successful use of bivalirudin for superior vena cava recanalization and stent placement in a child with heparin-induced thrombocytopenia. | Pediatric cardiology 20080701 |
| Antiplatelet and anticoagulant agents: key differences in mechanisms of action, clinical application, and therapeutic benefit in patients with non-ST-segment-elevation acute coronary syndromes. | Current opinion in cardiology 20080701 |
| 2007 Guideline update for unstable angina/non-ST-segment elevation myocardial infarction: focus on antiplatelet and anticoagulant therapies. | The Annals of pharmacotherapy 20080701 |
| Low plasma fibrinogen levels with the Clauss method during anticoagulation with bivalirudin. | Anesthesiology 20080701 |
| The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale. | American heart journal 20080701 |
| Treatment of ST-elevation myocardial infarction. | Future cardiology 20080701 |
| Reperfusion strategies in ST-elevation myocardial infarction--current status and perspectives for early and pre-hospital treatment. | Resuscitation 20080601 |
| [Direct thrombin inhibitors: pharmacology and application in cardiovascular anesthesia]. | Der Anaesthesist 20080601 |
| Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary intervention. | European heart journal 20080601 |
| Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | Chest 20080601 |
| Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | Chest 20080601 |
| Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | Chest 20080601 |
| [The ACUITY trial: one-year results]. | Giornale italiano di cardiologia (2006) 20080601 |
| The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes. | Therapeutics and clinical risk management 20080601 |
| Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin. | Vascular health and risk management 20080601 |
| Bivalirudin during primary PCI in acute myocardial infarction. | The New England journal of medicine 20080522 |
| Antithrombotic therapy to support primary PCI. | The New England journal of medicine 20080522 |
| Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. | Journal of the American College of Cardiology 20080506 |
| New anticoagulant agents: direct thrombin inhibitors. | Cardiology clinics 20080501 |
| What anti-thrombotic therapy is best with primary PCI for acute ST elevation myocardial infarction: how should the HORIZONS trial change current practice? | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20080501 |
| Antiplatelet therapy in early management of non-ST-segment elevation acute coronary syndrome: the 2002 and 2007 guidelines from North America and Europe. | Journal of cardiovascular pharmacology 20080501 |
| Review of the 2005 American College of Cardiology, American Heart Association, and Society for Cardiovascular Interventions guidelines for adjunctive pharmacologic therapy during percutaneous coronary interventions: practical implications, new clinical data, and recommended guideline revisions. | American heart journal 20080501 |
| Off-pump exchange of short-term percutaneous ventricular assist device (VAD) to long-term implantable VAD in severe coagulopathy and multi-organ failure. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20080501 |
| Bivalirudin. | Thrombosis and haemostasis 20080501 |
| [Bivalirudin and cardiac surgery: two case reports]. | Giornale italiano di cardiologia (2006) 20080501 |
| The Role of Glycoprotein IIb/IIIa Inhibitors- A Promise Not Kept? | Current cardiology reviews 20080501 |
| Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. | Journal of the American College of Cardiology 20080429 |
| Current update on glycoprotein IIb-IIIa and direct thrombin inhibition in percutaneous coronary intervention for non-ST elevation acute coronary syndromes: balancing bleeding risk and antiplatelet efficacy. | Journal of interventional cardiology 20080401 |
| [Heparin induced thrombocytopenia and anticoagulation in renal replacemant therapy]. | Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 20080401 |
| Antithrombotic agents for acute coronary syndromes. | Cardiovascular & hematological agents in medicinal chemistry 20080401 |
| New anticoagulant strategies in ST elevation myocardial infarction: trials and clinical implications. | Vascular health and risk management 20080401 |
| Adjunct bivalirudin dosing protocol for neuro-endovascular procedures. | Journal of vascular and interventional neurology 20080401 |
| High-dose aprotinin effectively reduces blood loss during on-pump coronary artery bypass grafting with bivalirudin anticoagulation. | The Journal of thoracic and cardiovascular surgery 20080301 |
| Ischaemic events and bleeding in patients undergoing percutaneous coronary intervention with concomitant bivalirudin treatment. | EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20080301 |
| Abciximab: a reappraisal of its use in coronary care. | Biologics : targets & therapy 20080301 |
| Adjunct thrombus aspiration reduces mortality in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction with high-risk angiographic characteristics. | The American journal of cardiology 20080215 |
| 'Off-label' stent therapy 2-year comparison of drug-eluting versus bare-metal stents. | Journal of the American College of Cardiology 20080212 |
| Acute left atrial thrombus after recombinant factor VIIa administration during left ventricular assist device implantation in a patient with heparin-induced thrombocytopenia. | Anesthesia and analgesia 20080201 |
| Salivating for knowledge: potential pharmacological agents in tick saliva. | PLoS medicine 20080201 |
| [Anticoagulation in acute coronary syndrome. An update]. | Hamostaseologie 20080201 |
| Recent developments in acute coronary syndromes. | Clinical medicine (London, England) 20080201 |
| The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update. | Seminars in thrombosis and hemostasis 20080201 |
| Routine use of the direct thrombin inhibitor bivalirudin for off-pump coronary artery bypass grafting is safe and effective. | The heart surgery forum 20080101 |
| Pharmacological strategies for inhibition of thrombin activity. | Current pharmaceutical design 20080101 |
| Safety and efficacy of bivalirudin in acute coronary syndromes. | Current pharmaceutical design 20080101 |
| Pharmacoeconomics of anticoagulants in acute coronary syndrome and percutaneous coronary intervention. | Current pharmaceutical design 20080101 |
| Monitoring of bivalirudin anticoagulation during and after cardiopulmonary bypass using an ecarin-activated TEG system. | Journal of cardiac surgery 20080101 |
| A novel survival model of cardioplegic arrest and cardiopulmonary bypass in rats: a methodology paper. | Journal of cardiothoracic surgery 20080101 |
| Use of bivalirudin to prevent thrombosis following orthotopic liver transplantation in a patient with Budd-Chiari syndrome and a history of heparin-induced thrombocytopenia. | Annals of clinical and laboratory science 20080101 |
| Effect of modified ultrafiltration on bivalirudin elimination and postoperative blood loss after on-pump coronary artery bypass grafting: assessment of different filtration strategies. | Journal of cardiac surgery 20080101 |
| Heparin-induced thrombocytopenia: diagnosis and management. | Thrombosis research 20080101 |
| Brave new world: the current and future use of novel anticoagulants. | Thrombosis research 20080101 |
| Antithrombotic therapies in primary angioplasty: rationale, results and future directions. | Drugs 20080101 |
| Bivalirudin: in patients with acute coronary syndromes : planned for urgent or early intervention. | Drugs 20080101 |
| New anticoagulants in children. | Hematology. American Society of Hematology. Education Program 20080101 |
| Implementing an innovative consent form: the PREDICT experience. | Implementation science : IS 20080101 |
| Quest for 'innovative strategies' in primary PCI: clot busters or devices (protection vs suction) or both? A story in search of an end. | Indian heart journal 20080101 |
| Antithrombotics for PCI: an indigenous direct thrombin inhibitor (DTI) makes the cut. | Indian heart journal 20080101 |
| Safety and efficacy of indigenously developed and manufactured bivalirudin in moderate/high-risk Indian patients undergoing percutaneous coronary intervention: the Bivaflo Registry. | Indian heart journal 20080101 |
| Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial. | JAMA 20071205 |
| Thrombin-activated thrombelastography for evaluation of thrombin interaction with thrombin inhibitors. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20071201 |
| Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY. | Cardiovascular drugs and therapy 20071201 |
| [Direct thrombin inhibition in interventional cardiology. The ACUITY trial]. | Hamostaseologie 20071201 |
| Efficacy and safety of bivalirudin versus heparins in reduction of cardiac outcomes in acute coronary syndrome and percutaneous coronary interventions. | Journal of cardiovascular pharmacology and therapeutics 20071201 |
| [Gp IIb/IIIa receptor antagonists in acute coronary syndromes with no ST elevation]. | Archives des maladies du coeur et des vaisseaux 20071201 |
| Focus on thrombin: alternative anticoagulants. | Seminars in cardiothoracic and vascular anesthesia 20071201 |
| Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. | The American journal of cardiology 20071101 |
| Survey of pharmacist-managed inpatient anticoagulation services. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20071101 |
| Drug-induced immune thrombocytopenia. | The New England journal of medicine 20071101 |
| Variegin, a novel fast and tight binding thrombin inhibitor from the tropical bont tick. | The Journal of biological chemistry 20071005 |
| Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents. | American heart journal 20071001 |
| Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin. | Anesthesia and analgesia 20071001 |
| Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI). | Minerva cardioangiologica 20071001 |
| [Heparin-induced thrombocytopenia]. | Revista espanola de cardiologia 20071001 |
| [Optimizing antithrombotic therapy in non-ST-elevation acute coronary syndrome]. | Revista espanola de cardiologia 20071001 |
| Does bivalirudin reduce the incidence of bleeding in patients with acute coronary syndromes undergoing PCI? | Nature clinical practice. Cardiovascular medicine 20070901 |
| Off-pump coronary artery bypass with bivalirudin for patients with heparin-induced thrombocytopenia or antiplatelet factor four/heparin antibodies. | The Annals of thoracic surgery 20070901 |
| Invited commentary. | The Annals of thoracic surgery 20070901 |
| Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastography. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20070901 |
| Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia. | Current cardiology reports 20070901 |
| Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects. | Cardiovascular & hematological disorders drug targets 20070901 |
| Effects of unfractionated heparin and glycoprotein IIb/IIIa antagonists versus bivalirdin on myeloperoxidase release from neutrophils. | Arteriosclerosis, thrombosis, and vascular biology 20070801 |
| Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin. | The American journal of cardiology 20070801 |
| Pilot dose-finding and safety study of bivalirudin in infants <6 months of age with thrombosis. | Journal of thrombosis and haemostasis : JTH 20070801 |
| Direct thrombin inhibition with bivalirudin as an antithrombotic strategy in general and interventional cardiology. | Expert opinion on drug metabolism & toxicology 20070801 |
| Beyond unfractionated heparin and warfarin: current and future advances. | Circulation 20070731 |
| Influence of bivalirudin on tissue factor-triggered coagulation. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20070701 |
| Monitoring direct thrombin inhibitors with a plasma diluted thrombin time. | Thrombosis and haemostasis 20070701 |
| New anticoagulant options for ST-elevation myocardial infarction and unstable angina pectoris/non-ST-elevation myocardial infarction. | Current cardiology reports 20070701 |
| Interatrial septal defect closure for cerebrovascular accidents: exploring the role of various anticoagulants. | The Journal of invasive cardiology 20070701 |
| Antithrombotic strategies in non-ST elevation acute coronary syndromes: focus on bivalirudin. | Future cardiology 20070701 |
| Association of prerandomization anticoagulant switching with bleeding in the setting of percutaneous coronary intervention (A REPLACE-2 analysis). | The American journal of cardiology 20070615 |
| Variations in the use of emergency PCI for the treatment of re-infarction following intravenous fibrinolytic therapy: impact on outcomes in HERO-2. | European heart journal 20070601 |
| Managing acute coronary syndrome: evidence-based approaches. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070601 |
| Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. | Journal of interventional cardiology 20070601 |
| Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention. | The American journal of cardiology 20070601 |
| Fondaparinux as a treatment option for heparin-induced thrombocytopenia. | Pharmacotherapy 20070601 |
| The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT. | Biologics : targets & therapy 20070601 |
| Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. | European heart journal 20070501 |
| Comparison of patient outcomes with bivalirudin versus unfractionated heparin in percutaneous coronary intervention. | Pharmacotherapy 20070501 |
| Successful use of bivalirudin as anticoagulant for ECMO in a patient with acute HIT. | The Annals of thoracic surgery 20070501 |
| The safety of a bivalirudin-based approach in patients undergoing rotational atherectomy. | The Journal of invasive cardiology 20070501 |
| Anticoagulant therapy in acute coronary syndromes. | Future cardiology 20070501 |
| Heparin resistance in acute coronary syndromes. | Journal of thrombosis and thrombolysis 20070401 |
| Heparin-induced thrombocytopenia: treatment options and special considerations. | Pharmacotherapy 20070401 |
| Impact of smart infusion technology on administration of anticoagulants (unfractionated Heparin, Argatroban, Lepirudin, and Bivalirudin). | The American journal of cardiology 20070401 |
| Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome. | Vascular health and risk management 20070401 |
| Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. | Journal of the American College of Cardiology 20070327 |
| ACUITY-PCI: one drug does not fit all. | Lancet (London, England) 20070317 |
| Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. | Lancet (London, England) 20070317 |
| Bivalirudin in acute coronary syndromes. | The New England journal of medicine 20070308 |
| Bivalirudin in acute coronary syndromes. | The New England journal of medicine 20070308 |
| Differential effects of direct thrombin inhibitors and antithrombin-dependent anticoagulants on the dynamics of clot formation. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20070301 |
| Current incidence and clinical outcomes of bivalirudin administration among patients undergoing primary coronary intervention for stent thrombosis elevation acute myocardial infarction. | Coronary artery disease 20070301 |
| Transradial approach for carotid artery stenting: a feasibility study. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20070215 |
| Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial. | The Annals of thoracic surgery 20070201 |
| Effect of combined anticoagulation using heparin and bivalirudin on the hemostatic and inflammatory responses to cardiopulmonary bypass in the rat. | Anesthesiology 20070201 |
| Bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in drug-eluting stent implantations in the absence of acute myocardial infarction: clinical and economic results. | The Journal of invasive cardiology 20070201 |
| Bivalirudin and DES: a PCI strategy that pays. | The Journal of invasive cardiology 20070201 |
| Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery. | Journal of cardiothoracic and vascular anesthesia 20070201 |
| Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. | Expert review of cardiovascular therapy 20070101 |
| Deep hypothermic circulatory arrest and bivalirudin use in a patient with heparin-induced thrombocytopenia and antiphospholipid syndrome. | Journal of cardiac surgery 20070101 |
| First human case description of TandemHeart-assisted high-risk percutaneous balloon aortic valvuloplasty using bivalirudin anticoagulation. | The Journal of invasive cardiology 20070101 |
| [The best of thrombosis in 2006]. | Archives des maladies du coeur et des vaisseaux 20070101 |
| Bivalirudin anticoagulation for cardiopulmonary bypass: an unusual case. | Texas Heart Institute journal 20070101 |
| Blood pressure and risks of vascular complications after percutaneous coronary intervention. | Dimensions of critical care nursing : DCCN 20070101 |
| Severe heparin-induced thrombocytopenia: when the obvious is not obvious, a case report. | Journal of medical case reports 20070101 |
| Evidence-based medical therapy of patients with acute coronary syndromes. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20070101 |
| Similar success rates with bivalirudin and unfractionated heparin in bare-metal stent implantation. | Cardiovascular and interventional radiology 20070101 |
| Sulodexide for hemodialysis anticoagulation in heparin-induced thrombocytopenia type II. | Journal of nephrology 20070101 |
| Interventional cardiology in Israel at 2005 - state of practice. | Acute cardiac care 20070101 |
| Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant. | Journal of cardiothoracic surgery 20070101 |
| Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin allergy. | Perfusion 20070101 |
| Heparin-induced thrombocytopenia: a general review. | Journal of infusion nursing : the official publication of the Infusion Nurses Society 20070101 |
| Direct antithrombins: mechanisms, trials, and role in contemporary interventional medicine. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20070101 |
| Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors. | Reviews in cardiovascular medicine 20070101 |
| The use of antithrombotics for acute coronary syndromes in the emergency department: considerations and impact. | Progress in cardiovascular diseases 20070101 |
| Endovascular treatment of a renal artery stenosis: techniques, indications, results. Role of embolic protection devices (part 2). | Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery 20070101 |
| Glycoprotein IIb/IIIa inhibitors: questioning indications and treatment algorithms. | Cardiovascular revascularization medicine : including molecular interventions 20070101 |
| The safety of bivalirudin during elective percutaneous coronary interventions in heart transplant patients. | Cardiology journal 20070101 |
| [Anticoagulant therapy and cardiopulmonary bypass]. | Archivos de cardiologia de Mexico 20070101 |
| Bivalirudin: a new promising direct antithrombin. | Indian heart journal 20070101 |
| Heparin induced thrombocytopenia management with bivalirudin. | Indian heart journal 20070101 |
| Heparin-induced thrombocytopenia. | The New England journal of medicine 20061214 |
| Bivalirudin in percutaneous coronary intervention. | Vascular health and risk management 20061201 |
| Fondaparinux in the management of patients with ST-elevation acute myocardial infarction. | Vascular health and risk management 20061201 |
| Bivalirudin for patients with acute coronary syndromes. | The New England journal of medicine 20061123 |
| Accounting for ACUITY. | The New England journal of medicine 20061123 |
| Promotion of proinflammatory interactions between platelets and monocytes by unfractionated heparin. | Heart (British Cardiac Society) 20061101 |
| Bolus-only platelet glycoprotein IIb-IIIa inhibition during percutaneous coronary intervention. | The Journal of invasive cardiology 20061101 |
| Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20061101 |
| Angiographic and clinical outcomes of bivalirudin versus heparin in patients with acute coronary syndrome undergoing percutaneous coronary intervention. | The Canadian journal of cardiology 20061101 |
| Heparin-induced thrombocytopenia: a review. | Seminars in thrombosis and hemostasis 20061101 |
| Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model. | Clinical therapeutics 20061101 |
| [Clinical use of a new class of anticoagulant drugs: the direct thrombin inhibitors]. | Giornale italiano di cardiologia (2006) 20061101 |
| Recent developments in antithrombotic therapy: will sodium warfarin be a drug of the past? | Recent patents on cardiovascular drug discovery 20061101 |
| Successful percutaneous coronary intervention using bivalirudin in a patient with chronic lymphocytic leukemia and thrombocytopenia. | European journal of haematology 20061001 |
| Debate of adjunctive pharmacology for percutaneous coronary intervention: anticoagulation and clopidogrel are not (always) enough. | Journal of interventional cardiology 20061001 |
| Debate of adjunctive pharmacology for percutaneous coronary intervention: thrombin inhibitors and clopidogrel are enough. | Journal of interventional cardiology 20061001 |
| [Bivalirudin: a direct thrombin inhibitor in percutaneous coronary interventions]. | Ugeskrift for laeger 20060918 |
| Direct thrombin inhibition appears to be a safe and effective anticoagulant for percutaneous bypass graft interventions. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20060901 |
| Bivalirudin provides rapid, effective, and reliable anticoagulation during off-pump coronary revascularization: results of the 'EVOLUTION OFF' trial. | Anesthesia and analgesia 20060901 |
| Risk stratification of patients with acute anterior myocardial infarction and right bundle-branch block: importance of QRS duration and early ST-segment resolution after fibrinolytic therapy. | Circulation 20060822 |
| Successful anticoagulation with bivalirudin in antithrombin-deficient pediatric patient undergoing stent placement. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20060801 |
| Greater inhibitory effects of bivalirudin compared with unfractionated heparin plus eptifibitide on thrombin-induced platelet activation. | Coronary artery disease 20060801 |
| Switching from Enoxaparin to Bivalirudin in Patients with Acute Coronary Syndromes without ST-segment Elevation who Undergo Percutaneous Coronary Intervention. Results from SWITCH--a multicenter clinical trial. | The Journal of invasive cardiology 20060801 |
| Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk. | Heart (British Cardiac Society) 20060701 |
| Heparin-induced thrombocytopenia and cardiovascular diseases. | American heart journal 20060701 |
| Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial. | American heart journal 20060701 |
| Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial. | American heart journal 20060701 |
| Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: an analysis from HERO-2. | Lancet (London, England) 20060624 |
| A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial. | Journal of the American College of Cardiology 20060620 |
| The future of an illusion. | Journal of the American College of Cardiology 20060620 |
| Planned versus provisional use of glycoprotein IIb/IIIa inhibitors in smokers undergoing percutaneous coronary intervention. | The American journal of cardiology 20060615 |
| Bivalirudin for anticoagulation in mechanical aortic valve replacement and heparin-induced thrombocytopenia. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20060601 |
| Angiographic adverse events, creatine kinase-MB elevation, and ischemic end points complicating percutaneous coronary intervention (a REPLACE-2 substudy). | The American journal of cardiology 20060601 |
| Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20060601 |
| Bivalirudin anticoagulation for a patient with hypercoagulable immune syndromes undergoing mitral valve surgery. | The Annals of thoracic surgery 20060601 |
| Bivalirudin in peripheral interventions. | Techniques in vascular and interventional radiology 20060601 |
| Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome. | The American journal of cardiology 20060515 |
| Measurement of patients' bivalirudin plasma levels by a thrombelastograph ecarin clotting time assay: a comparison to a standard activated clotting time. | Anesthesia and analgesia 20060501 |
| Cost-effectiveness analysis of antithrombotic therapy in nonurgent percutaneous coronary intervention. | Pharmacotherapy 20060501 |
| The vulnerable endothelium: priming the vascular endothelium for thrombosis with unfractionated heparin: biologic plausibility for observations from the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial (Am J Heart 2005;150:189-92). | American heart journal 20060501 |
| Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial. | American heart journal 20060501 |
| Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunction. | Pharmacotherapy 20060401 |
| Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia. | Pharmacotherapy 20060401 |
| Frequency of recurrent ST-elevation myocardial infarction after fibrinolytic therapy in a different territory as a manifestation of multiple unstable coronary arterial plaques. | The American journal of cardiology 20060401 |
| Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis. | Circulation 20060307 |
| Clinical development of bivalirudin (Angiox): rationale for thrombin-specific anticoagulation in percutaneous coronary intervention and acute coronary syndromes. | International journal of clinical practice 20060301 |
| Anticoagulation for cardiopulmonary bypass: is a replacement for heparin on the horizon? | The Journal of thoracic and cardiovascular surgery 20060301 |
| A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study. | The Journal of thoracic and cardiovascular surgery 20060301 |
| Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF study. | The Journal of thoracic and cardiovascular surgery 20060301 |
| Anti-thrombotic effect of bivalirudin compared with eptifibatide and unfractionated heparin in diabetic patients: an ex vivo human study. | Thrombosis and haemostasis 20060301 |
| Transitioning from heparin to bivalirudin in patients undergoing ad hoc transradial interventional procedures: a pilot study. | The Journal of invasive cardiology 20060301 |
| Use of bivalirudin as the foundation anticoagulant during percutaneous peripheral interventions. | The Journal of invasive cardiology 20060301 |
| Emerging anticoagulants: mechanism of action and future potential. | Vnitrni lekarstvi 20060301 |
| Thrombin inhibitors and cardiopulmonary bypass. | The journal of extra-corporeal technology 20060301 |
| Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both? | Vascular health and risk management 20060301 |
| Treatment of heparin-induced thrombocytopenia in cardiovascular patients. | Expert opinion on pharmacotherapy 20060201 |
| Bivalirudin use in carotid endarterectomy in a patient with heparin-induced thrombocytopenia. | The Annals of pharmacotherapy 20060201 |
| Case 1-2006: off-pump coronary artery bypass graft surgery anticoagulation with bivalirudin: a patient with heparin-induced thrombocytopenia syndrome type II and renal failure. | Journal of cardiothoracic and vascular anesthesia 20060201 |
| Treatment of heparin-induced thrombocytopenia: is there a role for bivalirudin? | Pharmacotherapy 20060201 |
| [Mechanism of thrombosis: physiopathology, role of thrombin and its inhibition by modern therapies]. | Archives des maladies du coeur et des vaisseaux 20060201 |
| [Direct thrombin inhibitors in coronary angioplasty. Value of bivalirudin ]. | Archives des maladies du coeur et des vaisseaux 20060201 |
| [Present and future developments of antithrombotic agents]. | Archives des maladies du coeur et des vaisseaux 20060201 |
| [Antithrombotic agents in clinical practice]. | Archives des maladies du coeur et des vaisseaux 20060201 |
| Use of bivalirudin to treat heparin-induced thrombocytopenia in a patient with idiopathic giant-cell myocarditis. | Connecticut medicine 20060201 |
| Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. | Journal of the American College of Cardiology 20060103 |
| Increased expression of platelet P-selectin and formation of platelet-leukocyte aggregates in blood from patients treated with unfractionated heparin plus eptifibatide compared with bivalirudin. | Thrombosis research 20060101 |
| Inhibition of thrombin: relevance to anti-thrombosis strategy. | Frontiers in bioscience : a journal and virtual library 20060101 |
| Prognostic differences between different types of bundle branch block during the early phase of acute myocardial infarction: insights from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. | European heart journal 20060101 |
| [The management of patients with heparin-induced thrombocytopenia]. | Hamostaseologie 20060101 |
| Heparin-induced thrombocytopenia and cardiovascular patients: recognition and treatment. | Progress in cardiovascular nursing 20060101 |
| Cardiopulmonary bypass for complex cardiac surgery using bivalirudin anticoagulation in a patient with heparin antibodies. | Journal of cardiac surgery 20060101 |
| When heparin causes thrombosis: significance, recognition, and management of heparin-induced thrombocytopenia in dialysis patients. | Seminars in dialysis 20060101 |
| Bivalirudin versus unfractionated heparin in patients undergoing percutaneous coronary intervention after acute myocardial infarction. | Cardiovascular revascularization medicine : including molecular interventions 20060101 |
| New anticoagulants. | Hematology. American Society of Hematology. Education Program 20060101 |
| A comparative study on the cost of new antibiotics and drugs of other therapeutic categories. | PloS one 20060101 |
| Practical guidelines for the use of anticoagulants in the catheterization laboratory. | Reviews in cardiovascular medicine 20060101 |
| Bivalirudin in acute coronary syndromes and percutaneous coronary intervention. | Reviews in cardiovascular medicine 20060101 |
| Platelet protagonist/antagonist: understanding the distinguishing characteristics of anticoagulants. | Reviews in cardiovascular medicine 20060101 |
| Economic implications of bivalirudin in the cardiac catheterization laboratory. | Reviews in cardiovascular medicine 20060101 |
| Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction. | Reviews in cardiovascular medicine 20060101 |
| Carotid artery stenting with neuroprotection: assessing the learning curve and treatment outcome. | American journal of surgery 20051201 |
| Bivalirudin anticoagulation for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia. | Canadian journal of anaesthesia = Journal canadien d'anesthesie 20051201 |
| Bivalirudin vs heparin in percutaneous coronary intervention: a pooled analysis. | Journal of cardiovascular pharmacology and therapeutics 20051201 |
| Bivalirudin: role in current percutaneous coronary intervention practice. | British journal of hospital medicine (London, England : 2005) 20051201 |
| [Direct and indirect antithrombins in acute coronary syndromes]. | Wiener klinische Wochenschrift 20051201 |
| Sensitivity of a modified ACT test to levels of bivalirudin used during cardiac surgery. | The journal of extra-corporeal technology 20051201 |
| Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation. | Thrombosis and haemostasis 20051101 |
| Adjunctive Antiplatelet / Antithrombotic therapy in percutaneous coronary intervention. | EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20051101 |
| Bivalirudin: a direct thrombin inhibitor used during percutaneous coronary intervention. | Future cardiology 20051101 |
| Percutaneous coronary intervention-related bleeding risk factors in current practice. | The Annals of pharmacotherapy 20051001 |
| Presence of direct thrombin inhibitors can affect the results and interpretation of lupus anticoagulant testing. | American journal of clinical pathology 20051001 |
| Brachytherapy and bivalirudin evaluation study. | American heart journal 20051001 |
| The effects of bivalirudin compared with those of unfractionated heparin plus eptifibatide on inflammation and thrombin generation and activity during coronary intervention. | Coronary artery disease 20050901 |
| Effectiveness of the concomitant use of bivalirudin and drug-eluting stents (from the prospective, multicenter BivAlirudin and Drug-Eluting STents [ADEST] study). | The American journal of cardiology 20050901 |
| Bivalirudin as an anticoagulation agent: safety and efficacy in peripheral interventions. | Journal of vascular and interventional radiology : JVIR 20050901 |
| Heparin and other rapidly acting anticoagulants. | Seminars in vascular surgery 20050901 |
| Drug insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options. | Nature clinical practice. Cardiovascular medicine 20050901 |
| Use of bivalirudin as an anticoagulant during cardiopulmonary bypass. | The journal of extra-corporeal technology 20050901 |
| [Haemostaseology]. | Der Internist 20050801 |
| Routine bivalirudin use in percutaneous carotid interventions. | Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 20050801 |
| A safety and feasibility report of combined direct thrombin and GP IIb/IIIa inhibition with bivalirudin and tirofiban in peripheral vascular disease intervention: treating critical limb ischemia like acute coronary syndrome. | The Journal of invasive cardiology 20050801 |
| New antithrombotics in the prevention of thromboembolic disease. | European journal of internal medicine 20050801 |
| Should bivalirudin be the anticoagulant of choice for percutaneous coronary intervention? | Nature clinical practice. Cardiovascular medicine 20050801 |
| Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes. | Journal of the American College of Cardiology 20050705 |
| Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patients with potential heparin-induced thrombocytopenia. | The Annals of thoracic surgery 20050701 |
| Invited commentary. | The Annals of thoracic surgery 20050701 |
| Bivalirudin versus heparin as an antithrombotic agent in patients who undergo percutaneous saphenous vein graft intervention with a distal protection device. | The American journal of cardiology 20050701 |
| Direct thrombin inhibitors. | Current cardiology reports 20050701 |
| Predictors of in-hospital and 30-day complications of peripheral vascular interventions using bivalirudin as the primary anticoagulant: results from the APPROVE Registry. | The Journal of invasive cardiology 20050701 |
| Bivalirudin as an adjunct to acute coronary intervention in post-operative myocardial infarction. | The Journal of invasive cardiology 20050701 |
| Successful percutaneous coronary intervention in a patient with severe haemophilia A using bivalirudin as the sole procedural anticoagulant. | Haemophilia : the official journal of the World Federation of Hemophilia 20050701 |
| Bivalirudin: a review. | Expert opinion on pharmacotherapy 20050701 |
| Evolving management strategies for heparin-induced thrombocytopenia. | Seminars in hematology 20050701 |
| Update on heparin-induced thrombocytopenia and cardiovascular interventions. | Seminars in hematology 20050701 |
| Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial. | Journal of the American College of Cardiology 20050621 |
| Inhibition of platelet aggregation with eptifibatide, bivalirudin, and heparin in patients undergoing percutaneous coronary intervention receiving clopidogrel pretreatment (The PharmacoDynamic Evaluation of Angiomax, Clopidogrel with or without INtegrilin [DEACON] study). | The American journal of cardiology 20050615 |
| Assessment of hemostatic activation during cardiopulmonary bypass for coronary artery bypass grafting with bivalirudin: results of a pilot study. | The Journal of thoracic and cardiovascular surgery 20050601 |
| What is the learning curve for carotid artery stenting with neuroprotection? Analysis of 200 consecutive cases at an academic institution. | Perspectives in vascular surgery and endovascular therapy 20050601 |
| [Direct inhibition of thrombin. A new strategy for the treatment of atrial fibrillation and acute coronary syndrome?]. | Herz 20050501 |
| Safety and feasibility of Bivalirudin with either Cypher and Taxus drug-eluting stent during percutaneous coronary intervention. | EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20050501 |
| Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical center. | The American journal of cardiology 20050315 |
| Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial). | The American journal of cardiology 20050301 |
| Optimizing management of hirudin anticoagulation. | The journal of extra-corporeal technology 20050301 |
| Diagnosis and management of heparin-induced thrombocytopenia. | Expert review of cardiovascular therapy 20050301 |
| PCI with bivalirudin and provisional GP IIb/IIIa inhibition is more cost-effective than heparin plus routine GP IIb/IIIa inhibition. Commentary. | Evidence-based cardiovascular medicine 20050301 |
| New anticoagulants for the prevention and treatment of venous thromboembolism. | Vascular health and risk management 20050301 |
| Eptifibatide-associated acute, profound thrombocytopenia. | The Annals of pharmacotherapy 20050201 |
| Direct thrombin inhibitors (part 2 of 2). | The Journal of invasive cardiology 20050201 |
| Use of bivalirudin, a direct thrombin inhibitor, and its reversal with modified ultrafiltration during heart transplantation in a patient with heparin-induced thrombocytopenia. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20050201 |
| Complications in peripheral vascular interventions: emerging role of direct thrombin inhibitors. | Journal of vascular and interventional radiology : JVIR 20050201 |
| Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines. | European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20050101 |
| Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors. | American heart journal 20050101 |
| Thrombin-directed inhibitors: pharmacology and clinical use. | American heart journal 20050101 |
| [The best of thrombosis in 2004]. | Archives des maladies du coeur et des vaisseaux 20050101 |
| Safety of bivalirudin during percutaneous coronary interventions in patients with abnormal renal function. | International journal of cardiovascular interventions 20050101 |
| Anticoagulation management and cardiac surgery in patients with heparin-induced thrombocytopenia. | Seminars in thoracic and cardiovascular surgery 20050101 |
| Bivalirudin: a review of its use in patients undergoing percutaneous coronary intervention. | Drugs 20050101 |
| Anticoagulant use in patients with chronic renal impairment. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20050101 |
| Antiplatelet agents in patients undergoing percutaneous coronary intervention: how many and how much? | American journal of cardiovascular drugs : drugs, devices, and other interventions 20050101 |
| Adoption of Angiomax at Christus Santa Rosa Medical Center decreases costs and increases satisfaction. | The Journal of cardiovascular management : the official journal of the American College of Cardiovascular Administrators 20050101 |
| Heparin-induced thrombocytopenia: an update. | Thrombosis journal 20050101 |
| New trends in anticoagulant treatments. | Lupus 20050101 |
| Bivalirudin compared with IIb/IIIa inhibitors in patients with in-stent restenosis undergoing intracoronary brachytherapy. | Cardiovascular revascularization medicine : including molecular interventions 20050101 |
| Intracoronary macrothrombus formation during percutaneous coronary intervention despite optimal activated clotting time using bivalirudin--a case report. | Angiology 20050101 |
| A successful anticoagulation protocol for the first HeartMate II implantation in the United States. | Texas Heart Institute journal 20050101 |
| Bivalirudin: pharmacology and clinical applications. | Cardiovascular drug reviews 20050101 |
| Severe argatroban-induced coagulopathy in a patient with a history of heparin-induced thrombocytopenia. | The Annals of thoracic surgery 20041201 |
| Cardiopulmonary bypass with bivalirudin in type II heparin-induced thrombocytopenia. | The Annals of thoracic surgery 20041201 |
| Effect of bivalirudin on length of stay in the recovery area after percutaneous coronary intervention compared with heparin alone, heparin + abciximab, or heparin + eptifibatide. | The American journal of cardiology 20041201 |
| Drugs for percutaneous coronary interventions. | The Medical letter on drugs and therapeutics 20041201 |
| Current role of antithrombotic agents in the treatment of acute coronary syndromes. | Seminars in thrombosis and hemostasis 20041201 |
| Anticoagulant monitoring techniques in a heparin-induced thrombocytopenia patient undergoing cardiopulmonary bypass using bivalirudin anticoagulant. | The journal of extra-corporeal technology 20041201 |
| Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial. | Journal of the American College of Cardiology 20041102 |
| Economic impact of new interventional therapies: are we asking the right questions? | Journal of the American College of Cardiology 20041102 |
| Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale. | American heart journal 20041101 |
| The Angiomax Peripheral Procedure Registry of Vascular Events Trial (APPROVE): in-hospital and 30-day results. | The Journal of invasive cardiology 20041101 |
| Bivalirudin versus heparin as an antithrombotic agent in patients treated with a sirolimus-eluting stent. | The American journal of cardiology 20041015 |
| Novel antithrombotic agents: indirect synthetic inhibitors of factor Xa and direct thrombin inhibitors. Evidences from clinical studies. | Current medicinal chemistry. Cardiovascular and hematological agents 20041001 |
| Effects of pentasaccharide (fondaparinux) and direct thrombin inhibitors on coagulation testing. | Archives of pathology & laboratory medicine 20041001 |
| Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy. | Journal of the American College of Cardiology 20040915 |
| Value of monitoring activated clotting time when bivalirudin is used as the sole anticoagulation agent for percutaneous coronary intervention. | The American journal of cardiology 20040915 |
| Comparing direct thrombin inhibitors using aPTT, ecarin clotting times, and thrombin inhibitor management testing. | The Annals of pharmacotherapy 20040901 |
| Use of bivalirudin instead of heparin during a percutaneous coronary intervention in a patient with severe thrombocytopenia. | The Journal of invasive cardiology 20040901 |
| Anticoagulation with bivalirudin during percutaneous coronary intervention for ST-segment elevation myocardial infarction. | The Journal of invasive cardiology 20040901 |
| Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. | Chest 20040901 |
| Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. | Chest 20040901 |
| Visual compatibility of bivalirudin with selected drugs. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20040901 |
| Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention. | Circulation 20040824 |
| Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. | JAMA 20040811 |
| An overview of antithrombins in peripheral vascular interventions. | The Journal of invasive cardiology 20040801 |
| Unfractionated heparin in cardiology: redefining the standard of practice. | Pharmacotherapy 20040801 |
| Current and future antithrombotic agents in children. | Expert review of cardiovascular therapy 20040701 |
| Direct antithrombins: new perspectives in cardiovascular medicine. | Current medicinal chemistry. Cardiovascular and hematological agents 20040701 |
| Reversal of direct thrombin inhibition after cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia. | Anesthesia and analgesia 20040601 |
| Successful multi-vessel percutaneous coronary intervention with bivalirudin in a patient with severe hemophilia A: a case report and review of literature. | The Journal of invasive cardiology 20040601 |
| Bivalirudin-associated intracoronary thrombosis during gamma-brachytherapy and its experimental validation in acute swine model. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20040601 |
| Percutaneous interventions in patients with immune-mediated heparin-induced thrombocytopenia. | Seminars in thrombosis and hemostasis 20040601 |
| The use of direct thrombin inhibitors in cardiovascular surgery in patients with heparin-induced thrombocytopenia. | Seminars in thrombosis and hemostasis 20040601 |
| Bivalirudin in PCI: an overview of the REPLACE-2 trial. | Seminars in thrombosis and hemostasis 20040601 |
| Bivalirudin, blood loss, and graft patency in coronary artery bypass surgery. | Seminars in thrombosis and hemostasis 20040601 |
| Plasma-modified ACT can be used to monitor bivalirudin (Angiomax) anticoagulation for on-pump cardiopulmonary bypass surgery in a patient with heparin-induced thrombocytopenia. | The journal of extra-corporeal technology 20040601 |
| Validation of the i-STAT handheld activated clotting time for use with bivalirudin. | The American journal of cardiology 20040515 |
| Resolution of intracoronary thrombus with direct thrombin inhibition in a cocaine abuser. | Heart (British Cardiac Society) 20040501 |
| Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial). | The American journal of cardiology 20040501 |
| The use of bivalirudin to prevent subacute thrombosis during drug-eluting stent implantation. | The Journal of invasive cardiology 20040501 |
| New anticoagulation. | The Journal of invasive cardiology 20040501 |
| Novel uses for current and future direct thrombin inhibitors: focus on ximelagatran and bivalirudin. | Expert opinion on investigational drugs 20040501 |
| Liquid chromatography method for determination of bivalirudin in human plasma and urine using automated ortho-phthalaldehyde derivatization and fluorescence detection. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040405 |
| Effect of direct thrombin inhibitors, bivalirudin, lepirudin, and argatroban, on prothrombin time and INR values. | American journal of clinical pathology 20040401 |
| Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery. | The Annals of thoracic surgery 20040301 |
| Bivalirudin: an anticoagulant option for percutaneous coronary intervention. | Expert review of cardiovascular therapy 20040301 |
| Bivalent direct thrombin inhibitors: hirudin and bivalirudin. | Best practice & research. Clinical haematology 20040301 |
| Selective use of bivalirudin to reduce post-PCI vascular complications. | Critical pathways in cardiology 20040301 |
| Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. | The American journal of cardiology 20040201 |
| Antibodies against lepirudin are polyspecific and recognize epitopes on bivalirudin. | Blood 20040115 |
| Bivalirudin for endovascular intervention in acute ischemic stroke: case report. | Neurosurgery 20040101 |
| Benefits of direct angioplasty for women and men with acute myocardial infarction: results of the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes Angioplasty (GUSTO II-B) Angioplasty Substudy. | American heart journal 20040101 |
| Direct thrombin inhibitors for anticoagulation. | The Annals of pharmacotherapy 20040101 |
| Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20040101 |
| Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration. | Thrombosis research 20040101 |
| Addition of heparin to contrast media is associated with increased bleeding and peripheral vascular complications during percutaneous coronary intervention with bivalirudin and drug-eluting stents. | Cardiovascular radiation medicine 20040101 |
| [Oral antithrombins and the future of antithrombotic therapy]. | Revista espanola de cardiologia 20040101 |
| Clinical potential of oral direct thrombin inhibitors in the prevention and treatment of venous thromboembolism. | Drugs 20040101 |
| Update on acute coronary syndromes and implications for therapy. | Expert opinion on investigational drugs 20031201 |
| Heparin-induced thrombocytopenia and cardiac surgery. | The Annals of thoracic surgery 20031201 |
| Bivalirudin as alternative to both danaparoid and heparin in off-pump coronary artery bypass grafting. | The Journal of thoracic and cardiovascular surgery 20031201 |
| Bivalirudin alone in the treatment of acute myocardial infarction. | The Journal of invasive cardiology 20031201 |
| Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis. | Circulation 20031125 |
| Comparison of effectiveness and safety of three different antithrombotic regimens (bivalirudin, eptifibatide, and heparin) in preventing myocardial ischemia during percutaneous coronary intervention. | The American journal of cardiology 20031101 |
| The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results. | The Journal of invasive cardiology 20031101 |
| Advances in antithrombin therapy for ST-elevation myocardial infarction. | Chinese medical journal 20031101 |
| Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials. | The American journal of cardiology 20031015 |
| Direct thrombin inhibitor therapy in the cardiovascular patient. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20031015 |
| Argatroban for off-pump coronary artery bypass surgery. | Anesthesia and analgesia 20031001 |
| Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where? | American heart journal 20031001 |
| Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia. | Journal of cardiothoracic and vascular anesthesia 20031001 |
| Bivalirudin in percutaneous coronary intervention. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030915 |
| Peptidomimetic thrombin inhibitors. | Pathophysiology of haemostasis and thrombosis 20030901 |
| Can bivalirudin and provisional GP IIb/IIIa blockade REPLACE heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention? | Expert opinion on pharmacotherapy 20030801 |
| Contemporary use of antiplatelet therapies in percutaneous coronary interventions. | Coronary artery disease 20030801 |
| Heparin-induced thrombocytopenia and cardiac surgery. | The Annals of thoracic surgery 20030801 |
| Current anticoagulant therapy--unmet clinical needs. | Thrombosis research 20030715 |
| Economic impact of bleeding complications and the role of antithrombotic therapies in percutaneous coronary intervention. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030715 |
| Bivalirudin in peripheral vascular interventions: a single center experience. | The Journal of invasive cardiology 20030701 |
| Bivalirudin use in off-pump myocardial revascularization in patients with heparin-induced thrombocytopenia [corrected]. | The Annals of thoracic surgery 20030701 |
| Hirulog-like peptide reduces restenosis and expression of tissue factor and transforming growth factor-beta in carotid artery of atherosclerotic rabbits. | Atherosclerosis 20030701 |
| Bivalirudin as a foundation anticoagulant in peripheral vascular disease: a safe and feasible alternative for renal and iliac interventions. | The Journal of invasive cardiology 20030601 |
| Evolving role of bivalirudin in percutaneous coronary interventions; impact of the REPLACE-2 study. | Expert opinion on investigational drugs 20030601 |
| An assessment of different filter systems for extracorporeal elimination of bivalirudin: an in vitro study. | Anesthesia and analgesia 20030501 |
| Correlation of point-of-care ecarin clotting time versus activated clotting time with bivalirudin concentrations. | The American journal of cardiology 20030501 |
| In-hospital complications of peripheral vascular interventions using unfractionated heparin as the primary anticoagulant. | The Journal of invasive cardiology 20030501 |
| Direct thrombin inhibitors. | Expert opinion on pharmacotherapy 20030501 |
| Predicting the pharmacology of thrombin inhibitors. | Journal of thrombosis and haemostasis : JTH 20030501 |
| Anticoagulation in acute cardiac care in patients with chronic kidney disease. | American heart journal 20030401 |
| Management of thrombotic and cardiovascular disorders in the new millenium. | Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20030401 |
| Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition. | The American journal of cardiology 20030315 |
| Informed consent during the clinical emergency of acute myocardial infarction (HERO-2 consent substudy): a prospective observational study. | Lancet (London, England) 20030315 |
| Bivalirudin (Angiomax) use during intracoronary brachytherapy may predispose to acute closure. | Journal of cardiovascular pharmacology and therapeutics 20030301 |
| Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. | JAMA 20030219 |
| Should bivalirudin replace heparin during percutaneous coronary interventions? | JAMA 20030219 |
| The evolving role of direct thrombin inhibitors in acute coronary syndromes. | Journal of the American College of Cardiology 20030219 |
| Bivalirudin monitored with the ecarin clotting time for anticoagulation during cardiopulmonary bypass. | Anesthesia and analgesia 20030201 |
| Clinician update: direct thrombin inhibitors in acute coronary syndromes. | Journal of thrombosis and thrombolysis 20030201 |
| Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia. | Seminars in dialysis 20030101 |
| Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass. | The Annals of thoracic surgery 20030101 |
| Direct thrombin inhibitors in cardiac disease. | Cardiovascular toxicology 20030101 |
| A 24-hour continuous infusion study of bivalirudin in the rat. | International journal of toxicology 20030101 |
| Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood. | Cell biochemistry and biophysics 20030101 |
| New anticoagulants: current status and future potential. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20030101 |
| Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery. | The Annals of thoracic surgery 20021201 |
| A Bayesian ordinal model for heterogeneity in a multi-centre myocardial infarction clinical trial. | Statistics in medicine 20021030 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20021001 |
| Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion. | European heart journal 20020901 |
| Direct thrombin inhibitors in acute coronary syndromes. | Lancet (London, England) 20020810 |
| Bivalirudin: a direct thrombin inhibitor for percutaneous transluminal coronary angioplasty. | Pharmacotherapy 20020801 |
| Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures. | Hamostaseologie 20020801 |
| Direct thrombin inhibitors. | Seminars in hematology 20020701 |
| Pharmacology and clinical use of bivalirudin. | The Annals of pharmacotherapy 20020601 |
| Bivalirudin: an anticoagulant for acute coronary syndromes and coronary interventions. | Expert opinion on pharmacotherapy 20020601 |
| Absolute and relative truth in clinical trials. | Lancet (London, England) 20020601 |
| Clinical pharmacology of bivalirudin. | Pharmacotherapy 20020601 |
| Bivalirudin administration during percutaneous coronary intervention: emphasis on high-risk patients. | Pharmacotherapy 20020601 |
| A practical cost analysis of bivalirudin. | Pharmacotherapy 20020601 |
| The role of thrombin inhibition during percutaneous coronary intervention. | Pharmacotherapy 20020601 |
| Selective inhibition of coagulation factors: advances in antithrombotic therapy. | Seminars in thrombosis and hemostasis 20020601 |
| Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and gender. | Clinical pharmacology and therapeutics 20020601 |
| Decreased platelet reactivity in blood anticoagulated with bivalirudin or enoxaparin compared with unfractionated heparin: implications for coronary intervention. | Journal of thrombosis and thrombolysis 20020601 |
| Heparin, bivalirudin, and reduction of complications during percutaneous coronary intervention. | Pharmacotherapy 20020601 |
| Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET). | American heart journal 20020501 |
| Direct thrombin inhibitors. | Thrombosis research 20020501 |
| Pharmacodynamic profile of the direct thrombin antagonist bivalirudin given in combination with the glycoprotein IIb/IIIa antagonist eptifibatide. | American heart journal 20020401 |
| Building a stronger foundation: improved antithrombin therapy with bivalirudin in percutaneous coronary intervention. | The Journal of invasive cardiology 20020401 |
| Overcoming heparin limitations in high-risk percutaneous coronary intervention: the alternative strategy-- replacing heparin with bivalirudin. | The Journal of invasive cardiology 20020401 |
| New drugs 2002. Part II. | Nursing 20020401 |
| Direct thrombin inhibitors for percutaneous coronary intervention in the current era of platelet glycoprotein IIb/IIIa inhibition. | Journal of interventional cardiology 20020401 |
| Percutaneous coronary intervention with bivalirudin anticoagulation, immediate sheath removal, and early ambulation: a feasibility study with implications for day-stay procedures. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20020301 |
| Publication policy, informed consent, and the randomized clinical trial. | American heart journal 20020201 |
| Improved efficacy and less bleeding: further evidence of a unique uncoupling of benefit and risk with bivalirudin. | American heart journal 20020201 |
| Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction. | American heart journal 20020201 |
| Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data. | Lancet (London, England) 20020126 |
| Bivalirudin: a direct thrombin inhibitor. | Clinical therapeutics 20020101 |
| Bivalirudin: a review of its potential place in the management of acute coronary syndromes. | Drugs 20020101 |
| [What is new in antithrombotic treatment?]. | Annales de biologie clinique 20020101 |
| Management of patients with acute coronary syndromes: what is the clinical role of direct thrombin inhibitors? | Drugs 20020101 |
| Optimal treatment and current situation in reperfusion after thrombolysis for acute myocardial infarction. | Annals of medicine 20020101 |
| Current anticoagulation options in percutaneous intervention: designing patient-specific strategies. | Reviews in cardiovascular medicine 20020101 |
| Reversing anticoagulants both old and new. | Canadian journal of anaesthesia = Journal canadien d'anesthesie 20020101 |
| Current developments in antithrombotic therapy: the role of antithrombin agents. | Pathophysiology of haemostasis and thrombosis 20020101 |
| Heparin-induced thrombocytopenia: pathophysiology and new treatment options. | Pathophysiology of haemostasis and thrombosis 20020101 |
| A second look at bivalirudin. | American heart journal 20011201 |
| Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study. | American heart journal 20011201 |
| Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. | Lancet (London, England) 20011201 |
| Pharmacologic preservation of the hemostatic system during cardiac surgery. | The Annals of thoracic surgery 20011101 |
| [Fibrinolysis in myocardial infarction with EKG elevation. Optimization of myocardial reperfusion by treatment with antithrombotic agents]. | Archives des maladies du coeur et des vaisseaux 20011101 |
| Caspofungin acetate, bivalirudin. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20011001 |
| Bivalirudin for percutaneous coronary intervention and in acute coronary syndromes. | Current cardiology reports 20010901 |
| New anticoagulants. | American heart journal 20010801 |
| Direct thrombin inhibitors: are they the future of anticoagulation? | South Dakota journal of medicine 20010601 |
| Development and current applications of thrombin-specific inhibitors. | Current drug targets. Cardiovascular & haematological disorders 20010601 |
| Advances in the development of thrombin inhibitors. | Expert opinion on investigational drugs 20010501 |
| Laser-induced noninvasive vascular injury models in mice generate platelet- and coagulation-dependent thrombi. | The American journal of pathology 20010501 |
| Bivalirudin (Angiomax) for angioplasty. | The Medical letter on drugs and therapeutics 20010430 |
| [Direct thrombin antagonists]. | Herz 20010401 |
| Thrombin inhibitor approved for anticoagulation during angioplasty. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010301 |
| From the Food and Drug Administration. | JAMA 20010214 |
| Direct and indirect antithrombins. Heparins, low molecular weight heparins, heparinoids, and hirudin. | Clinics in geriatric medicine 20010201 |
| Ecarin clotting time is sensitive to heparinoids: comparison of two different techniques. | Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20010101 |
| Hirulog-like peptide reduces balloon catheter injury induced neointima formation in rat carotid artery without increase in bleeding tendency. | Journal of vascular research 20010101 |
| Bivalirudin: a new approach to anticoagulation. | Heart disease (Hagerstown, Md.) 20010101 |
| The use of bivalirudin in patients with renal impairment. | The Journal of invasive cardiology 20001201 |
| Hirulog-1 reduces expression of platelet-derived growth factor in neointima of rat carotid artery induced by balloon catheter injury. | Journal of vascular research 20000101 |
| Direct thrombin inhibitors. | Haemostasis 19991201 |
| Clinical outcomes of bivalirudin for ischemic heart disease. | Circulation 19991116 |
| Effective use of BCH-2763, a new potent injectable direct thrombin inhibitor, in combination with tissue plasminogen activator (tPA) in a rat arterial thrombolysis model. | Thrombosis and haemostasis 19980701 |
| Transcellular signaling and pharmacological modulation of thrombin-induced production of plasminogen activator inhibitor-1 in vascular smooth muscle cells. | Seminars in thrombosis and hemostasis 19980101 |
| Inhibition by hirulog-1 of generation of plasminogen activator inhibitor-1 from vascular smooth-muscle cells induced by thrombin. | Journal of cardiovascular pharmacology 19970301 |
| Anticoagulant activity of Hirulog, a direct thrombin inhibitor, in humans. | Thrombosis and haemostasis 19930201 |
| Thrombin-specific inhibition by and slow cleavage of hirulog-1. | The Biochemical journal 19920501 |